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Streptococcus gordonii (S. gordonil) is being developed as a Gram-positive
expression vector for the expression of heterologous proteins. This bacterial
expression system takes advantage of the natural pathway of protein export and
anchoring on the surface of the bacterium. The expression of heterologous proteins
relies on the homologous recombination of a plasmid into the genome of S. gordonii.
The heterologous proteins are expressed constitutively in the bacterium and exported.
In order to purify the proteins away from the bacterium; the surface anchoring motifs
have been removed from the expressed protein. In this way, the proteins are directly
secreted into the medium. Results show that the protein is no longer associated with
the bacterium, but is present in the supernatant. In addition, about 3 mg/i of protein
can be produced without any optimization of growth conditions. In order to purify
these proteins away from the contaminating medium components, a histidine tag was
added to either the N or the C-terminus of the secreted heterologous protein. These
constructs were tested for their ability to bind to a metal affinity column and elute
under native conditions. The results of these experiments show that the proteins do
Redacted for Privacybind and elute under the appropriate conditions and that the proteins can be purified
10-15 fold from the medium. The addition of an affinity tag can be problematic
depending on the type of protein expressed. Perhaps enzyme activity is affected or the
protein is intended for therapeutic use. In this case, the affinity tag would need to be
removed from the target protein. In order to bothpurifya protein and remove the
purification tag, secreted fusions were constructed with a target protein fused to an
intein and chitin binding domain. These proteins were tested for the ability to bind
chitin beads and cleave between the target protein and the intein. Results show that
binding and cleavage do occur under the appropriate conditions. These data
demonstrate that S. gordonii can be used to express and secrete a variety of functional
proteins that can be purified to allow their downstream use as research tools,
therapeutics, or vaccine antigens.©Copyright by Dawn M. Myscofski
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Streptococcus
Introduction
The Streptococcus family contains a variety of members, both
pathogenic and non-pathogenic. Members of this genus are Gram-positive and are
characterized as catalase negative cocci (spherical in shape), that usually grow in
chains of cocci. Early this century, scientists began identifying and distinguishing the
various streptococci that were being discovered. This task was difficult due to the
differences in the physiological characteristics of the various bacteria, the lack of
standards for classifying the bacteria, and the continual discovery of new organisms.
Because of these difficulties, some Gram-positive cocci have been reclassified as
recently as a few years ago. Members within the Streptococcus genus are
distinguished from each other by their different hemolytic patterns; complete lysis of
blood cells or beta-hemolysis, incomplete lysis or aipha-hemolysis, and no lysis or
gamma-hemolysis (Murrayet al., 1998). In 1933,Dr. Rebecca Lancefield grouped
and characterized the beta-hemolytic streptococci by their serological properties,
differences in the cell surface carbohydrates or other antigens (Murrayet al., 1998).
These surface antigens were labeled alphabetically, resulting in the Lancefield
grouping system that includes groups A-H and K-V. Members of these groups can
then be further typed according to surface protein serology. Dr. Lancefield
successfully serotyped Group A Streptococcus or Streptococcus pyogenes (S.2
pyogenes), by its surface M protein (Lancefield, 1928). S. pyogenes is a medically
important bacterium; it is the causitive agent of strep throat or bacterial pharyngitis
and other disorders. More recently, strains of GAS have been discovered to cause
necrotizing fasciitis (Caparon, 2000); these bacteria are commonly referred to as
"flesh-eating" bacteria. Another medically important Lancefield group is Group B
Streptococcus or Streptococcus agalactiae, which causes neonatal sepsis and
meningitis (Murray etal., 1998).
Some streptococci do not possess the group specific cell wall antigens.
Streptococcus pneumoniae (S. pneumonaie) and the alpha and non-hemolytic
streptococci (called the viridans streptococci) have not been grouped this way and are
usually identified by other physiological properties (Murray etal., 1998). For
example, S. pneumoniae usually grows in pairs, or diplococci, which makes it easily
distinguishable from other streptococci. S. pneumoniae is a cause of bacterial
pneumonia, meningitis, and otitis media. Within the viridans group are a large group
of oral streptococci including Streptococcus mutans (S. mutans) and Streptococcus
gordonii (S. gordonii) (Russell, 2000). S. mutans is known to cause dental caries and
can also cause endocarditis. S. gordonii was thought to be associated with those
infections, but is now believed to be harmless in healthy individuals. S. gordonii is a
commensal bacterium that is found in the oral cavity of humans. It may be beneficial
in colonizing areas of the oral cavity that could be inhabited by more pathogenic
organisms, such as S. mutans.3
Surface protein chemistryofGram-positive bacteria
Most Gram-positive bacteria anchor surface proteins to their cell wall using a
conserved LPXTG anchor motif located near the carboxyl terminus (Fischetti et al.,
1990). These surface proteins consist of an N-terminal signal peptide, the exposed
surface protein, an anchor motif, a hydrophobic membrane spanning region, and a C-
terminal charged tail (Fischetti etal., 1990; Scbneewind etal., 1992). The signal
peptide directs the protein to the newly forming cell wall and is cleaved by signal
peptidase (Pugsley, 1993). The protein is extruded but held within the wall by the
chargedtailwhile an enzyme, termed sortase (Navarre and Schneewind, 1994),
cleaves the anchor motif between the threonine and glycine. The new carboxyl
terminus of the threonine is then amide linked to the crossbridge of the cell wall
(Schneewind etal., 1995). Though this mechanism was discovered in Staphylococcus
aureus (Navarre and Schneewind, 1999; Schneewind etal., 1995), it is thought to be
highly conserved in Gram-positive bacteria, albeit with minor variations in the
chemistry of the crossbridge between bacterial species. The bacteria anchor surface
proteins that are used in the signaling of other bacteria, the invasion of host cells, the
adhesion to host tissue, and the evasion of the host's immune response (Fischetti,
2000).
The M protein is an example of this class of proteins and is found on the
surface of Streptococcus pyogenes. The M protein has a major role in streptococcal
pathogenesis by facilitating bacterial adhesion to host cells and evasion of the host's
immune system due to its antiphagocytic properties (Ellen and Gibbons, 1972). There
are more than 100 serotypes of the M protein, with the continual discovery of new4
serotypes. The protein's high variability is what allows the organism to repeatedly
infect individuals lacking the appropriate immunological memory. The protein
consists of the highly variable regions at the N-terminus, the A- and B-repeat regions
(Fischetti, 2000). The C-repeat region is much more highly conserved, but is poorly
detected by the host's immune system. Following the C-repeat region is the D-repeat
region and a proline/glycine rich region which is fused to the highly conserved Gram-
positive anchor region (Fischetti, 2000). The C-repeat region of the M6 protein is
currently being developed as both a purified subunit vaccine (Bessen and Fischetti,
1988; Bessen and Fischetti, 1990; Bronze etal., 1992) and whole cell vaccine
expressed on S. gordonii. The C-repeat region of this protein is the portion of the
protein that can confer immunity to S. pyogenes infection across many serotypes
(Bronze etal., 1992).
S. gordonii as a vaccine vector and protein expression system
Usually, bacterial cells must be forced to take up foreign DNA by infection
with phage or by electroporation. S. gordonii is naturally competent to take up DNA
(Pozzi, 1987; Pozzi etal., 1990) and so is a useful genetic system with which to work.
S. gordonii strain GP25 1 was created to recombine transformed plasmid DNA into the
genome using flanking regions present on both molecules (Oggioni and Pozzi, 1996).
It then expresses the protein from a genomic promoter. Because S. gordonii is
regarded as a harmless commensal, it may be useful as both an expression vector for
purified subunit vaccines (Bessen and Fischetti, 1988; Bessen and Fischetti, 1990;
Bronze et al., 1992) or other therapeutic proteins, or a whole cell vaccine delivery5
system to induce protective immunity at the oral mucosa (Medaglini et al., 1995;
Pozzi etal., 1994). Whole cell vaccine delivery may be preferable to subunit
vaccination because the vaccine vector (bacterium) actively multiplies at the mucosal
surface where the pathogen would likely invade (Fischetti etal., 1996), and stimulates
a secretory immune response (Cardenas and Clements, 1992). The fact that S.
gordonii is naturally transformable makes it not only a good candidate as a vaccine
vector, but also makes the bacterium a useful expression system.
S. gordonii was developed as an expression system for the production of
heterologous proteins. S. gordonii strain GP25 1, which is used to express proteins
was chosen based on its natural competence for DNA as well as the absence of
proteases in the medium that could degrade proteins. The plasmid recombines the
gene of interest into the genome of the bacterium, so expression of the protein is
stable. This unique system, termed SPEX for surface protein expression, provides a
few options for expression of heterologous proteins that other systems cannot. This
system is more cost effective and easy to use than mammalian and yeast expression
systems, although Gram-negative expression systems such as Escherichia coli (E.
coli) are also cheap and easy to use. What distinguishes S. gordonii from E. coli
expression systems is that S. gordonii can either anchor the protein to the bacterial
surface using the natural conserved pathway, or can secrete the protein to be purified
from the medium. All that is required to affect this change is the removal of the
anchor region within the recombinant plasmid. E. coil systems require cell wall lysis
to recover the expressed protein from the periplasm, and much of the protein can be
insoluble. Yeast systems secrete proteins, but are expensive and also requireoptimization of the codon usage depending on the expressed protein (Sreekrishna et
al., 1997).
Goalsofthis thesis:
The primary goal of this study is to capitalize on the previous expression and
vaccine work in S. gordonii in order to create a versatile protein expression system for
the expression, secretion, and purification of proteins. The first objective is to secrete
stable heterologous proteins into the medium. This will be achieved by inserting a
stop codon prior to the anchor region of the recombinant Streptococcus pyogenes M6
protein. The expressed protein will be assayed for its presence as well as its stability
in the medium. Quantitation of M6 without any optimized growth and expression
modifications will be determined.
The next objective is to show that the secreted proteins can be purified away
from the medium components by expressing fused affinity tags and purifying the
fusion proteins over an Immobilized Metal Affinity Column. Both recombinant M6
and a Nuclease A (NucA) enzyme from Staphylococcus aureus will be expressed in S.
gordonii. These purified proteins will be assayed for enzyme activity (NucA) and
immunoreactivity after purification. The proteins will be quantified and fold
purification will be determined.
Finally, after the development of a purification system, the goal is to both
purify both recombinant M6 and NucA proteins using an affinity tag, then cleave the
unwanted affinity tag to release the target protein. The proteins that are cleaved using7
this method will be assayed for the presence of a cleaved product, as well as activity
and stability.
This study will help to determine whether this SPEX system has promise as a
broadly applicable protein expression system. It will also show what types of
optimizations are needed in order to increase the utility of the system.
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Abstract
Using a conserved pathway for surface protein extrusion, a system has been
developed for the expression and secretion of proteins from Gram-positive bacteria.
As proof-of-concept, the Streptococcus gordonii Challis strain has been engineered to
express a series of recombinant proteins fused to the conserved region of the M6
protein of Streptococcus pyogenes. In the prototype surface protein expression
system, (SPEX), the recombinant M6 protein is anchored to the surface of S. gordonii
cells expressing it. In order to over-express the protein and easily purify it away from
the bacteria, the protein was modified to enable it to be secreted into the media. To
accomplish this, a stop codon was introduced into the gene just prior to the anchor
region using site-directed mutagenesis. Using enzyme linked immunosorbant assays,
it was possible to quantitate the amount of protein expressed using this system. With
little or no optimization, 3 mg of protein per liter of culture was expressed and
secreted into the media of a bacterial culture grown to an0D600equal to 1.0. This
system should be broadly applicable for the expression and secretion of a variety of
proteins (antigens, hormones, and enzymes) directly into the media.
Introduction
Most Gram-positive bacteria anchor surface proteins to their cell wall using a
conserved LPXTG motif located proximal to the carboxyl terminus of these proteins
(Fischetti et al., 1990). This type of protein consists of a N-terminal signal peptide,
the ectodomain of the surface protein, an anchor motif, a hydrophobic region, and a C-
terminal charged tail (Fischetti etal., 1990; Schneewind etal., 1992). The signal12
peptide is cleaved by signal peptidase at the cell wall (Pugsley, 1993). The protein is
extruded and an as of yet uncharacterized enzyme, referred to as the sortase (Navarre
and Schneewind, 1994), cleaves the anchor motif between the threonine and glycine.
The new carboxyl terminus of the threonine is then amide linked to the pentaglycine
crossbridge of the cell wall (Schneewindetal.,1995).
The M protein is an example of this class of proteins and is found on the
surface ofStreptococcus pyogenes.The M protein has a major role in streptococcal
pathogenesis by facilitating bacterial adhesion to host cells and evasion of the host's
immune system (Ellen and Gibbons, 1972). S.pyogenescauses strep throat in
children and is responsible for considerable pathology and medical costs every year in
the U.S. (Pichichero, 1992). Furthermore, it has been implicated in the etiology of
rheumatic fever caused by cross-reactivity of antibodies to the M protein with
myocardial tissue (Bessenet al.,1995; Kaplan, 1963; Monet al.,1996). The ability
of S.pyogenesto evade the immune system is due in large part to the antigenic
variation within the amino-terminus of the M protein. Because of this variability,
there are more than 100 recognized serotypes of the M protein, which makes it a poor
candidate antigen for vaccination. However, antibodies against a carboxyl-proximal
conserved region of the M protein called the C-repeat region (CRR) have been shown
to be protective when this polypeptide was used as a subunit vaccine in mice (Bessen
and Fischetti, 1988; Bessen and Fischetti, 1990; Bronzeet al.,1992), and when this
region of the M protein was produced in a vaccinia virus system that was used as a
vaccine vector (Fischettiet al.,1989). This region of the protein is currently being13
studied as a target for both subunit and whole bacterial vaccines against S.pyogenes
infection in humans.
S.gordonli(Challis strain) is a Gram-positive commensal bacterium that is
found in the oral cavity of humans. Because it is regarded as harmless, it may be
useful as an antigen delivery system to induce protective immunity against pathogenic
organisms that normally infect through the oral mucosa. This method of vaccine
delivery is preferable to the subunit vaccination because the vaccine vector
(bacterium) actively multiplies at the mucosal surface and is efficient at stimulating a
secretory immune response without requiring either secondary immunizations or
ancillary immunostimulants (Cardenas and Clements, 1992). This bacteria expressing
an anchored protein has been used to inoculate mice to test for colonization, and
results indicate that colonization occurs and is apparently benign. In studies of a
recombinant S.gordoniiexpressing a hornet toxin antigen, it has been shown that both
a mucosal and systemic immune response against the antigen was detectable in
colonized mice (Medaglinietal.,1995).
In order to express and purif' proteins of interest, there are many different
expression systems available. The E. coli expression systems offer a cost-effective
way to produce protein on a large scale. Unfortunately, the proteins are often
aggregated in inclusion bodies and are inactive. Likewise, the proteins are sometimes
toxic to the bacterial cells and are thus poorly expressed or require an induction step.
Purification of the proteins involves lysis of the cells. This system also does not often
express functional eukaryotic proteins because of the need for post-translational
processing (Hockney, 1994). Mammalian cell expression systems produce functional14
proteins but the process is very expensive and requires tissue culture capabilities.
Also, there are some safety concerns when using transformed cells for the expression
of proteins for use in humans (Hilleman, 1990). Yeast expression systems have been
used to express functional eukaryotic proteins, and can process and secrete proteins.
These can also be produced on a large scale but are more expensive than bacterial
expression systems. Baculovirus systems can express functional eukaryotic proteins
on a large scale, but again this involves tissue culture techniques (insect cells) and
much time is required.
Therefore, as an alternative approach, we have sought to develop S. gordonii as
a surface protein expression vector (SPEX). Advantages of this system are that S.
gordonii can be used to produce protein on a large scale by taking advantage of a
natural pathway that is designed to export proteins of varying size and structure to the
outside of the bacterial cell. The expressed proteins can be either anchored on the
surface of the bacteria or secreted into the media and are therefore not likely to form
inclusion bodies. Anchored forms of several recombinant proteins have already been
successfully expressed this way (Medaglinietal.,1995; Pozzietal.,1992; Pozziet
al.,1994; Sharmaetal.,1996). In this work, we have sought to expand the utility of
the system to allow the secretion of proteins into the media where they can be easily
purified. As a model we have chosen to express the CRR of the M6 protein because
of the ability to quantitate protein expression by immunoassay, and to develop an
antigen expression system for future subunit vaccine trials.15
Materials and Methods
Bacterial strains and plasmids
Escherichia co/i DH5a, CJ236, or TG1 cells were grown in Luria-Bertani
broth or on Luria-Bertani medium containing 1.5% agar with the appropriate
antibiotics. S. gordonii (strain GP25 1) was made resistant to chloramphenicol (5
pgIml) by inserting the chloramphenicol acetyltransferase gene into wild type S.
gordonii (Challis strain) (Oggioni and Pozzi, 1996). GP25 1 is the recipient strain for
the introduction of foreign genes. S. gordonii (strain GP1223) is a recombinant strain
with kanamycin resistance (500 tg/ml) and expresses an inserted gene encoding the
first 16 N-terminal amino acids fused in frame with the last 220 C-terminal amino
acids of streptococcal M6 protein, with the A and B repeat regions deleted (Fischetti,
1991). The streptococci were grown in brain-heart infusion (BHI, Difco) broth or on
BHI agar plates. Recombinant plasmid pSMB 104, a derivative of pSMB55, (Oggioni
and Pozzi, 1996) was the prototype vector. It is a 5.66 Kb E. coli plasmid that does
not replicate inS. gordonii. It encodes emm6MO4, which encodes the signal peptide,
the first 16 N-terminal, and last 220 C-terminal amino acids of the M6 protein.
Flanking this gene (and a gene for erythromycin resistance) is a region of DNA
homologous to the genomic DNA surrounding the CAT gene in GP25 1. This allows
for recombination of the recombinant emm6 DNA and the resistance gene into the
chromosome. A recombinant S. gordonii with this plasmid inserted is functionally
similar to GP 1223, except that it is resistant to erythromycin. This strain, named here16
GP 104, is used as the positive control for expressing the anchored protein throughout
this study.
Recombinant DNA Techniques
Plasmid pM6STOP was constructed from pSMB 104 using oligonucleotide-
directed mutagenesis (Kunkeletal., 1987). The oligonucleotide STOP (5'CTAAGA-
GACAGTAATTACCGTCGACAGGTGAAACA3') was used to construct
pM6STOP. The stop codon was added prior to LPXTG and a Sail site was
introduced. The mutation was confirmed by restriction analysis with Sail and DNA
sequencing.
Bacterial Transformation
Frozen cells of naturally competent S. gordonii GP251 were prepared and
transformed as described (Pozzietal., 1990). Briefly, an overnight culture of GP251
cells were back diluted 1:10,000 in BHI containing 10% heat-inactivated FCS and
allowed to grow to an 0D600 of 0.05. Aliquots were removed every 15 minutes and
glycerol was added to a final concentration of 10%. The aliquots were frozen in liquid
nitrogen, and stored at -70°C. The cells were thawed and 0.5 .xg of DNA was added
and incubated for 45 mm at 37°C.
Plating and scoring of transformants on multilayered plates were also done as
previously described (Pozzi, 1987). Briefly, the cell/DNA mixture was added to
melted Bill agar with 5% defibrinated sheep blood. This mixture was plated,
incubated for 90 mm, and overlayed with an agar mixture containing erythromycin.17
Plates were incubated for 2 days at 37°C. Colonies were counted, picked with sterile
toothpicks, and streaked onto Bill plates containing the appropriate antibiotic.
Streak Blot
Potential transformants were picked from the multilayer plates using a sterile
toothpick and streaked in a 10 mm horizontal streak onto the surface of three BHI
plates containing either no antibiotics, erythromycin, or chloramphenicol (both 5
jig/mi). In addition to the putative transformants, each plate was streaked with GP1O4
and GP25 1 as positive and negative M6 controls, respectively. The streak blot was
performed as previously described (Pozzi, 1987). Briefly, a nitrocellulose membrane
was applied to the streaked surface of a Bill plate (no antibiotics) and allowed to
incubate at RT for 20 mm. The membrane was removed and incubated at 37°C for 30
mm, then baked at 80°C for 15 mm. The membrane was then blocked with TBS
containing 3% gelatin for 30 mm, washed for 30 mm in TTBS (TBS with 0.05%
Tween 20) and probed with anti-M6 10F5 monoclonal antibody (Jones etal., 1986) in
TTBS containing 1% gelatin for 3 hr. The membrane was washed 3X in TTBS for 5
mm, incubated with goat anti-mouse IgG conjugated to alkaline phosphatase for 2 hr,
then washed 2X in TTBS, 1X in TBS, and developed in alkaline phosphatase substrate
(BlO-RAD, Hercules, CA).
Immunoblot and Silver Stain Analysis of Supematant
Streptococci were grown to late stationary phase in Bill. The cells were
pelleted by centrifugation at 15,000 X g in a 1.5 ml microflige tube. 20 jil of
supematant was removed and 20 jil 2 X SDS sample buffer was added. The samples18
were boiled for 3 mm. The proteins were resolved by discontinuous gel
electrophoresis (SDS-PAGE), utilizing 10% polyacrylamide gels as described
previously (Schagger and von Jagow, 1987). The gels were then subjected to either
silver stain analysis (Switzeret al.,1979) (NOVEX, San Diego, CA) or immunoblot
analysis (Towbinet al.,1979) by blotting to nitrocellulose membrane, which was then
probed with the 10F5 monoclonal antibody.
ELISA
ELISA plates were coated overnight with 100.tl10F5 antibody at 5 mg/mi in
carbonate buffer. Plates were washed 5X with PBS/Tween (0.05%) using an EL404
microplate washer, (BlO-TEK Instruments, iNC., Wmooski VT), then blocked with
2% BSA in PBS/Tween for 60 mm at 37°C. Bacterial culture supernatant diluted in
PBS/Tween was added and incubated for 3 hr. The plates were again washed, then
probed with anti-M6 polyclonal antibody (1:1000) for 3 hr. The plates were washed
and incubated with diluted (1:3000) anti-rabbit IgG alkaline phosphatase conjugate
(Bio-Rad, Hercules, CA) for 2 hr. The plates were washed and developed with Sigma
phosphatase substrate at 1 mg/mi in 10% diethanolamine/3 mM MgC12, pH 10. The
plates were read on a Titertek Multiscan Plus (Flow Laboratories, McLean VA) and
analyzed using Delta Soft II software (Labsystems, Franklin ME). The experimental
titers were averaged and compared to the averaged control M6 titer to determine the
concentration of protein. These were then plotted on a graph versus optical density of
the bacterial cultures at 600 nm.19
Protein A assay
A Protein A assay was performed on cells expressing an anchored version of
the protein, GP 104, and cells expressing the secreted version of the protein, GPSTOP.
The protein A assay was performed as described previously (Coyleetal.,1997).
Briefly, cultures were grown to mid log phase,0D600of 0.65. The cells were pelleted
and washed 3X in PBS buffer containing 3% BSA and 0.02% NaN3. The cells were
then resuspended in buffer containing 1 0F5 monoclonal antibody and incubated for 3
hr at 37°C. The cells were then washed, incubated withS labeled Protein A
(Amersham, Arlington Heights, IL) for 30 mm at RT, and washed again. The
radioactive counts were determined using a Beckman LS3 801 scintillation counter.
Results
Cloning of Secreted M6 Protein
Using the previous work expressing surface-anchored foreign proteins in S.
gordonii as a starting point, a SPEX expression vector has been constructed for
expression of the protein and secretion into the media. pSMB 104 was derived from
previously constructed pSMBSS (Pozziet al.,1990) and used as the backbone plasmid
because it contained sites for homologous recombination into the S. gordonii (GP251)
genome. Within those sites are theemm6gene and a gene for erythromycin
resistance. Within theemm6gene, changes were made to allow secretion.
Specifically, a stop codon (TAA) was engineered into the sequence in-frame prior to
the sequences coding for the anchor (the TTA coding for leucine), which prevents the
anchor from being expressed at the protein level. ASailsite was also added in order20
to verify the mutation with restriction enzyme analysis and DNA gel electrophoresis.
After this confirmation, the putative positive clones were confirmed by sequencing.
Figure 2.1 (top) shows a schematic of the protein that is anchored. This protein
contains all of the domains required to anchor the protein to the cell wall, including
the LPSTG anchor motif, the hydrophobic region and the charged tail. The bottom
shows a schematic of the truncated protein that is secreted. The entire anchor region is
removed from this protein.
Figure 2.2, (top) shows a schematic of the highly conserved process of
anchoring proteins to the outside of the cell. The signal peptide targets the protein to
the cell wall, the signal peptide is cleaved by signal peptidase at the cell wall, and the
protein is taken through the cell wall. The hydrophobic region of the anchor spans the
cell wall and the chargedtailprevents the protein from being secreted prior to
anchoring. The final step in which the sortase cleaves the anchor motif between the
threonine and the glycine and the threonine is amide-linked to the cell wall
(Schneewind etal., 1995) is not shown in the schematic. Figure 2.2, (bottom) shows a
schematic of the secretion process that results from removal of the anchor region.
With no anchor motif, hydrophobic region, or chargedtail,the protein is not
retained at the cell wall for the anchoring process. The kinetics of the anchoring
process have not been fully studied and the sortase has not been characterized, so the
exact processes of protein recognition, binding, and enzymatic activity are not known.21
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Figure 2.1. A schematic representation of the functional domains of the
recombinant M6 protein. The top shows the protein that is anchored. The protein
consists of the signal sequence, the N-terminal region of 16 amino acids (NTR), the C
repeat region (CRR), D repeat region (DRR) and proline/glycine rich region (Pro/Gly),
and the anchor region of M6. The anchor region consists of the anchor motif, LPSTG,
the hydrophobic region, and the charged tail. The sortase cleaves between the T and
the 0 of the anchor motif. The bottom diagram shows the protein that is modified for
secretion. The anchor region has been removed by inserting a stop codon prior to the
anchor motif.22
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Figure 2.2. (Top) A schematic of the anchoring process. The protein is targeted to
the cell wall, the signal sequence is cleaved, and the protein is extruded and anchored
to the cell wall. (Bottom) A schematic of the secretion process. The protein is
targeted to the cell wall, the signal sequence is cleaved, and the protein is extruded and
secreted.23
Streak blot
After the structure of the plasmid was confirmed by sequencing, the DNA was
then transformed into S.gordonii.The transformants were plated onto multilayer
plates, the top layer containing erythromycin for selection. The colonies that grow
within the layers were thought to express the M6 protein, and were selected for further
analysis. These were streaked out onto BHI plates, and subjected to an immunological
streak blot analysis. Membranes were placed on the surface of the plates that had
incubated for 2 days at 3 7°C. The bacteria streaks and protein that had diffused into
the media were absorbed onto the membrane. The membrane was blocked and
incubated with 10F5 monoclonal antibody specific for the CRR of the protein. After
washing, the membrane was incubated with antibody specific to the first antibody
(goat anti-mouse) conjugated to alkaline phosphatase. Alkaline phosphatase substrate
was added, and a colorimetric reaction occurred where the M6 protein was bound to
the membrane. Figure 2.3 shows a streak blot that was performed on 2 different
recombinants suspected of expressing the secreted protein along with an anchored
control (GP1O4) and a non-expressing control (GP251). A black halo of cleaved
substrate can be seen around the secreting cells, in contrast to the discrete black lines
that are characteristic of the cells that anchor the protein. The non-expressing control
did not react with the antibody and did not exhibit a change in color. This data
suggests that the recombinants do not retain the protein on their cell wall, and the
proteins diffuse into the solid medium. This is in contrast to the proteins expressed on
the surface of the anchored control, which do not diffuse into the medium.24
Figure 2.3. Streak blotof S. gordonhisecretion recombinants. The blot shows
bacterial streaks of 2 recombinant S. gordonii (GPStop) expressing the secreted
protein (top). The anchored control (GP1O4) and a non-expressing control (GP251)
are also shown for comparison (bottom). A black halo of cleaved substrate can be
seen around the secreting cells (GPStop- 1 and GPStop-2), in contrast to the discrete
black lines of GP1O4. The GP251 did not exhibit a color change.25
Protein A assay
In order to analyze the protein expression in a more quantitative way, a
protein A assay was performed on the recombinants, as well as GP25 1 and GP 104.
This assay was developed (Coyle etal., 1997) to determine whether the protein was
associated with the cell wall and also to determine the relative levels of protein as
compared to the controls by detecting the radioactive counts for each sample. The
bacterial cells were grown to an0D600of 0.65, and incubated with 10F5 antibody,
then radioactive protein A, and the counts were then determined. The positive control
(GP1O4) would have a higher signal than the negative control (GP251), because there
is M6 protein anchored to the cell wall of GP1O4. Figure 2.4 shows the relative levels
of protein A associated with the secreting recombinants as compared to the controls.
GP1O4 (at 34545 average counts) has about twenty fold higher concentrations of
protein A associated with it than GP251 (1674 counts), GPStop-1 (1573 counts) and
GPStop-2 (1527 counts). The results obtained support the theory that the protein is
not associated with the bacterial cell wall of the secreting recombinants, but secreted
into the media. This experiment was performed on four sets of samples and is highly
reproducible when done in parallel. However, the numbers may not be reproducible
from one experiment to another depending on the age and lot of protein A used in the
experiments.
Immunoblot and Silver Stain Analysis
An immunoblot and silver stain were performed on the recombinants to see
how the protein migrated in comparison to the anchored version of the protein. There40000
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Figure 2.4. Protein A assay of S. gordonii cells. Bacterial cells were grown to an
0D600of 0.65. The bacteria were first incubated with antibody then with labeled
protein A, which binds the antibody, and the radioactive counts were determined.
GP 104 has about twenty fold higher concentration of protein A associated with it than
the negative control, GP251, and the experimental strains GPStop-1 and GPStop-2.27
was a concern about potential degradation of the protein as a result of the mutation.
The size of the two proteins should be the same on the blot, because there is only a
difference of four amino acids after cleavage and processing of the anchored protein in
the cell wall. Figure 2.5 shows an immunoblot of the supernatant from the secreted
and anchored recombinants. Figure 2.6 shows a silver stained gel of the supernatant
from the same bacteria. The size of the protein is predicted to be about 23.5 kDa, but
runs at about 29 kDa on both the immunoblot and the silver stained gel. From the
immunoblot, it is clear that there are not detectable degradation products formed in the
media after secretion of the protein, which suggests a lack of proteases in the media or
a stable protease resistant protein. From a culture of bacterium at an0D600of 0.65,
the secreting recombinants have much more protein in the media, whereas the
anchored construct produces very little soluble protein. If the cultures were allowed to
grow beyond an0D600of 1.0, the anchoring bacteria would naturally slough off much
of its protein, and the immunoblot would appear as if the concentrations were equal
(unpublished observations). From the silver stain, other secreted protein products are
detectable. These results show the contaminating protein products that will need to be
purified away from the recombinant protein.
ELISA
In order to quantitate the levels of protein produced at different growth periods
for the secreting strains, ELISAs were performed on the media from the secreting
bacterium. The bacteria were grown in BHI with erytbromycin and samples were
collected at an0D600= 0.5, 0.75, 1.0, 1.25 and 1.5. The samples were pelleted and the30
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Figure 2.5. Immunoblot of the culture media. An immunoblot was performed to
detect expressed protein in the supernatant from the secreted and anchored
recombinants. Lanes are as follows: lane 1-Low molecular weight marker, lane 2-
GPStop-1, lane 3-GPStop-2, lane 4-GP1O4, lane 5-GP251, and lane 6-purified M6
protein. The recombinant proteins migrate at 29 kDa. Note the lack of detectable
degradation products formed in the media after secretion of the protein. From a
culture of bacterium at an0D600of 0.65, GPStop-1 and 2 have much more protein in
the media than GP1O4.21 kDa
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Figure 2.6. Silver stain of the culture media. A silver stain was performed to show
the contaminating proteins in the culture media, and the relative concentrations of the
proteins as compared to the recombinant M6 protein. Lanes are as follows: lane 1-
Low molecular weight marker, lane 2-GPStop-1, lane 3-GPStop-2, lane 4-GP1O4, and
lane 5-GP25 1. The M6 protein is detectable in lanes 2 and 3 at approximately 29 kDa,
corresponding to the GPStop recombinants. GP1O4 did not produce enough protein to
be detected using this method.30
media removed and pH adjusted to 7.4 for analysis. Capture ELISAs were performed
by coating the plates with 1 0F5 antibody overnight, then adding a doubling dilution of
the media (in buffer) along side a known dilution of M6 control. The plates were
washed and incubated with polyclonal antisera specific for the CRR of M6, then with
antibody specific for the polyclonal antisera (goat anti-rabbit) conjugated to alkaline
phosphatase. The plates were then developed by adding alkaline phosphatase
colorimetric substrate and read on an ELISA plate reader. Figure 2.7 shows a graph of
protein expressed in mg/L versus OD. The results show that as the bacterium grows,
more protein is being made and secreted. After about an 0D600 of 1.0, the amount of
protein expressed does not continue to increase. From this system in its present form,
one can make about 3 mg/L of protein from a culture grown to an 0D600 of 1.0.
Discussion
Using the M6 protein of S. pyogenes as an experimental model, we have
developed an efficient bacterial expression system (SPEX) for production and
secretion of heterologous proteins from S. gordonii. It has been demonstrated that
exogenous DNA sequences can be fused to sequences specifying surface expression
on Gram-positive bacteria. In addition, it has been shown that stable transformation of
this recombinant DNA into S. gordonii occurs. The streak blot that was performed
shows that the protein is expressed in the transformants. Both the streak blots and the
protein A assay suggest that the protein is being secreted. The immunoblot shows that
the secreted protein is stable and migrates at the same rate as the anchored version of
the protein that is sloughed off into the media. The ELISAs were performed to3.5
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Figure 2.7. ELISA of secreted protein. Culture media was collected from cultures
grown to an 0D600= 0.5, 0.75, 1.0, 1.25 and 1.5. Capture ELISAs wereperformed on
the samples and compared to a known dilution of M6 protein. The results show an
increase in the amount of protein that is made and secreted over time. After about an
0D600of 1.0, the amount of protein expressed does not continue to increase. This
system can produce about 3 mg/L of protein from a culture grown to an0D600of 1.0.32
quantitate the amount of protein expressed in the media at different time points. The
results of the ELISA show that about 3 mg/L of protein can be expressed at an0D600
of 1.0.
There are a variety of future optimizations that can be considered for the SPEX
system. For instance, the promoter that drives the expression of this protein could be
replaced by other, perhaps more powerful, promoters in Gram-positive bacteria. In
addition, due to the highly conserved anchoring process in Gram-positive bacteria,
other genera could be used for the expression of heterologous proteins including those
in the Lactococcus or Lactobacillus species. These genera have the advantage of
being GRAS organisms for which there is a great deal of information available
regarding their growth and large-scale production due to their use in the food industry.
Likewise, expression cassettes based on high-copy plasmid vectors rather than a
single-site genomic insertion, may also enhance the expression of the protein by
introducing extra copies of the gene into the recombinant bacteria. Any or all of these
optimizations should result in the enhancement of the amount of protein produced by
Gram-positive vectors.
It should also be possible to introduce alterations in the structure of the protein
to facilitate downstream protein purification. Based on the results of the silverstained
protein gel, it will be necessary to purify the protein away from several contaminating
protein products in the media. One way this could be achieved is by engineering a
histidine tag (Hochuli, 1990) onto the carboxyl-terminus of the secreted protein.
Other alternatives include the addition of a GST binding domain (Smith and Johnson,
1988) or maltose-binding protein fusion (di Guan et al., 1988). If fusion proteins were33
a disadvantage, the addition of cleavage sites would allow for removal of the
heterologous protein from the remainder of the M6 protein or the affinity tags
following purification. To take that a step further, the anchored protein could be
altered by the addition of a cleavage site for easier purification. This would keep the
protein concentrated on the surface of the bacteria until harvest time. Some cleavage
options include a TEV cleavage domain (Parkset al.,1994), an intein fusion (Chong
etal.,1996), and a factor Xa domain (Magnussonetal.,1975).
Finally, the secreting recombinants should be studied in animal trials to
determine whether the organism will colonize, and whether the protein that is secreted
elicits an immune response. Much more is known about the ability of the anchoring
recombinant in inducing an immune response. When hornet toxin antigen was
expressed on the surface of S. gordonii, both a mucosal and a systemic immune
response was induced in mice (Medaglinietal.,1995). It is possible that this
secreting system could instead induce tolerance to the antigen expressed. If so, this
might provide a mechanism for preventing a variety of allergic responses or
autoimmune disorders.
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Abstract
Streptococcus gordonii (S. gordonii) has been used as a Gram-positive
bacterial expression vector for secreted or surface anchored recombinant proteins.
Fusion of the Gram-positive bacterial N-terminal signal sequence to the target protein
is all that is required for efficient export. This system is termed SPEX for Surface
Proteinpression and has been used to express proteins for a variety of uses. In this
study, the SPEX system has been further developed by the construction of vectors that
express poly-histidine tagged fusion proteins. SPEX vectors were constructed with an
N-terminal or C-terminal histidine tag. The C-repeat region (CRR) from
Streptococcus pyogenes M6 protein and the Staphylococcus aureus nuclease A
(NucA) enzyme were tested for expression. The fusion proteins were purified using
metal affinity chromatography (MAC). Results show that the fusion proteins were
expressed and secreted from S. gordonii with the his-tag at either the N- or C-terminal
position and could be purified using MAC. The M6 fusions retained
immunoreactivity after expression and purification as determined by immunoblots and
ELISA analyses. In addition, NucA fusions retained functional activity after
purification. The M6-his and NucA-his fusions were purified approximately 15- and
10- fold respectively using MAC. This study shows that the poly-histidine tag in
either the N- or C-terminal position is an efficient way to purify secreted heterologous
proteins from the supernatant of S. gordonii cultures. This study further illustrates the
value of the SPEX system for secreted expression and purification of proteins.40
Introduction
Currently there are few protein expression systems that secrete proteins
directly into the culture medium for immediate use or easy purification. Gram-
negative bacterial expression systems typically transport proteins into the periplasmic
space. Protein recovery requires lysis of the cell wall and purification of the protein
prior to use. Yeast expression systems can secrete proteins, but there are a variety of
optimizations such as codon usage and secretion signal sequences that are necessary
depending on the source of the proteins expressed (Sreekrishna et al.,1997).Yeast
proteolyticaily cleave and perform post-translational modifications of proteins, but
yield is often low and the process is more expensive than bacterial expression systems.
We have developed a Gram-positive protein expression system using
Streptococcus gordonii (S. gordonii) that permits either surface display or secretion of
heterologous proteins. Gram-positive bacteria have a unique and highly conserved
system of exporting proteins for anchoring on their surface (Fischetti et al.,1990;
Navarre and Schneewind,1994;Scbneewind etal.,1992).This mechanism for cell
wall anchoring has only been characterized in Staphylococcus aureus using Protein A,
but the mechanism is used as a model for most Gram-positive bacterial proteins that
contain the same motifs (Navarre and Schneewind,1999).The conserved proteins
consist of an N-terminal signal sequence that directs the protein through the cell wall,
a C-proximal LPXTG anchor motif, a hydrophobictransmembrane domain, and a
charged tail (Fischetti etal.,1990;Schneewind etal.,1992).Upon translocation of
the protein across the cell membrane, the signal peptide is cleaved. The protein is
extruded and the LPXTG anchor motif is cleaved between the threonine and the41
glycine. The threonine is then crosslinked to the cell wall via an amide linkage
(Navarre and Scbneewind, 1999).
The DNA sequence coding for anchored heterologous proteins can be changed
to express proteins that are not anchored, but instead secreted into the culture medium.
This can be accomplished by removing the entire anchor region, adding a stop codon
prior to the anchor, or making changes to the conserved regions such as the anchor
motif or the charged tail (Murakami etal., 1997; Myscofski and Hruby, 1998;
Schneewind etal., 1992). These are the processes by which proteins are purposefully
secreted for purification from the medium. In fact, the addition of a stop codon prior
to the anchor in the DNA is the basis for secreting proteins using the SPEX system.
S. gordonii, in general, has been a good model bacterium for the expression of
a variety of proteins. One method of expression inS. gordonii is the expression of
proteins from a plasmid. Proteins expressed from plasmids in S. gordonii include the
Bacil!us circu!ans cycloisomaltooligosaccharide glucanotransferase (Shiroza et al.,
1998),Porphyromonasgingiva!is PRP-C protein (Kataoka etal., 1999), and a
pertussis toxin Si subunit fusion protein (Lee etal., 1999). Plasmid expression
requires selection but is nevertheless a useful method.
Another method exists by which the DNA coding for the protein undergoes
homologous recombination into the genome of a recipient S. gordonii strain (GP25 i)
developed by Gianni Pozzi (Oggioni and Pozzi, 1996; Pozzi, 1987; Pozzi etal., 1990).
This method uses a plasmid (pSMB 104) that contains a Aemm6 gene and
erythromycin resistance gene flanked by regions that are homologous to the S.
gordonii strain GP25 1 genome. Within the homologous flanking region of the GP25 142
genome is a chioramphenicol resistance gene that is removed when a homologous
recombination event occurs. Recombinants are selected for the loss of
chloramphenicol resistance and the gain of erythromycin resistance along with
expression of the target protein. This method has been used to express both anchored
and secreted proteins including S. pyogenes M6 (Myscofski and Hruby, 1998; Pozzi et
al., 1992), Staphylococcal Nuclease A (Dutton etal., 2000), Escherichia coil heat
labile toxin B monomer (Ricci et al., 2000), fimbrillin proteins from Porphyromonas
gingivalis (Sharma etal., 1999; Shanna etal., 1996; Sharma etal., 1997) and an HIV-
1 gpl2O epitope (Pozzi etal., 1994) to name a few.
To increase the utility of the SPEX system in the laboratory, the expressed
proteins should be easily purified. Unlike E. co!i expression systems, proteins from
the secreted system do not require purification from a cell lysate. Purification of the
secreted proteins can be somewhat challenging nonetheless, due to the contaminating
medium components that can precipitate along with the recombinant protein. To date,
all of the heterologous proteins expressed using SPEX have been purified over a
variety of columns that rely on the size, charge, or solubility of the recombinant
protein versus other medium components. This process is time-consuming, requires
knowledge of the heterologous protein's chemical properties such as p1 and size, and
usually results in the loss of total protein yield.
The addition of affinity tags like poly-histidine (Janknecht et al., 1991;
Janknecht and Nordheim, 1992), or affinity protein fusions like maltose binding
protein (MBP) (di Guan etal., 1988) and glutathione-S-transferase (Smith and
Johnson, 1988) can help remedy this problem. The poly-histidine affinity tag has been43
the preferred epitope in expression and purification systems because it usually does
not interfere with downstream functions of purified proteins (Janknecht and
Nordheim, 1992). The poly-histidine tag is typically a short 6-10 mer peptide and
allows for easy purification using metal affinity chromatography. It also has many
detection methods commercially available including anti-his antibody (Clontech,
Qiagen, and Sigma) and metal-conjugated probes (Pierce Chemical Company and
Kirkegaard & Perry Labs). The other protein fusions using MBP or glutathione may
interfere with downstream functions of the recombinant protein (Hochuli, 1990).
Creating an expression and purification system that is versatile is the object of
this study. Therefore, eight new vectors with histidine tags have been created to
facilitate protein purification. The vectors were designed to express either an N or a
C-terminal poly-histidine tagged fusion protein with either the recombinant S.
pyogenesM6 protein or the Staphylococcusaureus (S. aureus)Nuclease A (NucA)
enzyme. The vectors were further differentiated by the exact location of the poly-
histidine tag on both the N and C-terminal ends.
Recombinant S.gordoniistrains were isolated that contain each expression
vector and were analyzed for protein expression and secretion. The positive
transformants were then used in comparative expression and purification studies.
Both the NucA and M6 recombinant fusion proteins were expressed and secreted with
both histidine tag configurations. All of the fusion proteins were purified over a metal
affinity colunm (MAC) and demonstrated binding and elution with imidazole. All of
the fusion proteins further demonstrated reactivity with metal affinity probes. NucA
was enzymatically active after purification and M6 was immunoreactive with M644
specific antibodies. The results of this study demonstrate that the SPEX system can be
used to secrete proteins with fused affinity tags directly into the medium where they
can be easily purified for subsequent downstream use as antigens or enzymes.
Materials and Methods
Bacterial strains and plasmids
Escherichia coil DH5cx, and TG1 cells were grown in Luria-Bertani (LB) broth
or on LB agar (Difco, Detroit, MI) containing 1.5% agar with the appropriate
antibiotics. S. gordonii (strain GP25 1) was made chloramphenicol resistant (5 jtg/ml)
by inserting the chioramphenicol acetyltransferase (CAT) gene into the genome of
wild type S. gordonii (Challis strain) (Oggioni and Pozzi, 1996). GP251 is the
recipient strain for the introduction of plasmids containing foreign genes. GP25 1 cells
were grown in brain-heart infusion (BHI, Difco) broth or on BHI agar plates. The
parent recombination plasmid pSMB 104, a derivative of pSMB55, (Oggioni and
Pozzi, 1996) is a 5.66 Kb plasmid that does not replicate inS. gordonii. pSMB 104
encodes emm6M 04, which contains the signal peptide, the first 16 N-terminal, and
last 220 C-terminal amino acids of the M6 protein. Flanking the M6 gene and an
erytbromycin resistance gene is a region of DNA homologous to the S. gordonil
GP25 1 genome. Within the homologous flanking region of the GP25 1 5. gordonii
genome is the CAT gene. This allows for homologous recombination of the target
genes from the plasmid into the S. gordonii chromosome. SP-01, formerly GPSTOP
(Myscofski and Hruby, 1998), was made by engineering a stop codon just prior to theLPXTG anchor region of theemm6gene in pSMB 104, and transforming GP25 1 with
the newly made p STOP plasmid (Myscofski and Hruby, 1998).
Recombinant Cloning
C-Terminal His-Tagged Vectors:
All mutagenesis and sequencing primers were ordered from Gibco BRL
(Rockville, MD). The oligonucleotide SH1O (5'AAGGAAACTAAGAGACAGCAC-
CATCACCATCACCATCACCATCACCATTAAGTTAACTTACCATCAACAGGT
GAAACAGCT3') was used to construct pM6H1O. The lO-histidine fragment
followed by a stop codon (followed by aHpaIsite for restriction enzyme verification)
was inserted prior to the LPXTG motif by mutagenesis (Kunkelet al.,1987). The
plasmid was transformed into TG1 cells and plated on LB plates with 100 jg/m1
ampicillin.
The oligonucleotide TSH1 0(5 'AAACAAGTTGAAAAAGCTTTACACCATCA-
CCATCACCATCACCATCACCATTAAGTTAACGAAGAAGCAAACAGCAAAT
TA3') was used to construct pM6TH1O. The lO-histidine fragment followed by a stop
codon was inserted just after theHindIIIsite in frame with the open reading frame to
create a truncated version of the recombinant M6. AHpaIsite was also introduced in
order to verify that the mutagenesis occurred. Both mutants were verified by
sequencing at the Central Services Laboratory (CSL, Oregon State University,
Corvallis, OR), using the following sequencing primer SEQ2 (5 'GACTGCTGAACT-
TGATAAGG3').46
For the NucA constructs, a double stranded complementary XhoI linker (plus
strand 5 'TTGGTTGAAGCTTGGAGCTCGAGGGAAGCTTGGTTGGT3') was
cloned into either the full length pM6H1O or the truncated pM6TH1O vectors by
cutting the vector with HindJII, removing the 5' phosphates with calf intestinal
phosphatase (Boebringer Mannheim, Indianapolis, IN), and cutting the double
stranded linker with HindlII and ligating with the vector overnight. The resulting
plasmid was transformed into DH5a cells and the DNA prepared, cut with 7ioI and
electrophoresed. The positive clones were sequenced. Those clones that had the
linker in the correct orientation (asymmetric linker) were cut with XhoI and KpnI. The
NucA gene was removed from pVE5232 (generously provided by Dr. Jean-Christophe
Piard) by cutting with )thol and KpnI and cloned into pM6H 10 and pM6TH 10
containing the linker.
N-Terminal His-Tagged Vectors:
Mutagenesis primer TB203 (5' GAAGTTAGTGCAGAATTCAGAGTGTTT-
CCT3') and its complement were used to insert an EcoRl site between amino acids 42
and 43 in the N-terminal region of the M protein in pSTOP, using the Quick Change
site directed mutagenesis kit from Stratagene (La Jolla, CA), yielding the plasmid
pStop:Eco. Histidine primer TB 199 (5'GGAATTCGCAGCACATCATCATCAT-
CATCATGGATCCGAATTCC3') or TB2O1 (5' GGGGTACCGCAGCACATCAT-
CATCATCATCATGGATCCGGTACCCC3') and their complements for the EcoRI
and KpnI site cloning respectively, were annealed and inserted either at the EcoRI site
in pStop:Eco or the KpnI site in pSTOP to yield pStop:EHis and pStop:KHis
respectively. Each linker consists of the cloning site flanking two alanine and six47
histidine codons. After sequence verification, all of the new constructions were
transformed into S. gordonii GP25 1 as described below.
Bacterial Transformation
Frozen stocks of naturally competent S. gordonii GP25 1 were prepared and
transformed as described (Pozzi et al., 1990). Briefly, an overnight culture ofGP25l
cells were back diluted 1:10,000 in BHI containing 10% heat-inactivated FCS and
allowed to grow to an 0D600 of 0.03. Aliquots were removed every 10-15 minutes and
glycerol was added to a final concentration of 10%. The aliquots were frozen in liquid
nitrogen, and stored at -70° C. The cell aliquots were thawed at 37° C and 0.5 jig of
each of the newly cloned plasmids was added. The cells were incubated at 37° C for
45 mm and then plated onto multilayer plates as described previously (Pozzi, 1987).
Briefly, the cell and DNA mixture was added to melted BHI agar with 5% defibrinated
sheep blood. This mixture was plated, incubated for 90 mm at370C, and overlayed
with an agar mixture containing erythromycin at 5 p.gIml. Plates were incubated for 2
days at 37° C. Colonies were counted, picked with sterile toothpicks, and streaked
onto BHI plates containing the appropriate antibiotic.
Streak Blot
Putative transformants were picked from the multilayer plates using a sterile
toothpick and streaked in a 10 mm diagonal streak onto the surface of three BHI plates
containing either no antibiotics, erythromycin, or chloramphenicol (both 5 pg/m1). In
addition to the putative transformants, each plate was streaked with SP-01 and GP251
as positive and negative M6 controls, respectively. Forselection of S. gordonii48
recombinant M6 strains, streak blots were performed as described previously (Pozzi,
1987). Briefly, a nitrocellulose membrane was applied to the surface of the streaked
BHI plate (no antibiotics) and allowed to incubate at room temperature for 20 mm.
The membrane was removed and incubated at 37°C for 30 mm, then baked at 80°C for
15 mm. The membrane was then blocked with tris buffered saline (TBS, pH 7.4)
containing 3% gelatin for 30 mm, washed for 30 mm in TTBS (TBS with 0.05%
Tween 20) and probed with anti-M6 I 0F5 monoclonal antibody (1:2000) (Jones et al.,
1986) in TTBS containing 1% gelatin for 3 hr. The membrane was washed 3X in
TTBS for 5 mm, incubated with goat anti-mouse IgG conjugated to alkaline
phosphatase (BioRad Laboratories, Hercules, CA) for 2 hr, then washed 2X in TTBS,
lxin TBS, and developed in alkaline phosphatase substrate (BioRad). For selection
of NucA strains, NucA expression was detected using a metachromatic agar diffusion
assay as described (Lachica etal., 1971). The untransformedrecipient strain GP251
was used as the negative control.
Column Chromatography, PAGE, and Blots
Recombinant streptococci were grown overnight to late stationary phase in
BHI with 5 j.ig/ml erythromycin. Cultures were centrifuged to pellet the cells and the
supernatant was filtered through a 0.2 J.tm filter and applied to a MAC column for
histidine tagged protein purification. MAC chromatography was performed using an
Amersham-Pharmacia AKTApurifier 10/100 FPLC (Amersham-Pharmacia Biotech
Inc., Piscataway, NJ). Approximately 10 ml of M6 or NucA overnight culture
supernatant from the various strains constructed were loaded on a 5 ml HiTrap49
chelating colunm (Amersham-Pharmacia Biotech Inc.) that was loaded withCoC12.
The column was washed with 2 column volumes of wash buffer (20 mM NatPO4 and
0.1 M NaCl) and the his-tagged proteins were eluted using wash buffer with 1 M
imidazole at 1 mllmin. One milliliter fractions were collected and tested for his-
immunoreactive protein using a dot blot. His-tagged immunoreactive fractions
identified using the dot blot were then subjected to SDS-polyacrylamide gel
electrophoresis (SDS-PAGE). NucA immunoreactive fractions were tested for
enzyme activity using a fluorescence enzyme assay as described previously (Dutton et
al., 2000) and the M6 immunoreactive fractions were quantified using a capture
ELISA. Protein concentration estimates on pre and post-MAC samples were
performed according to the manufacturer's instructions using Bradford reagent
(BioRad).
For dot blot analysis, 100 p.1 of the 1 ml fractions were transferred directly to
PVDF membrane (Millipore Corp., Bedford, MA) using a 96 well dot blot apparatus
(Stratagene). For protein molecular weight analysis, 15 p.1 of the immunoreactive
fractions were added to 5 p.1 of 4 X SDS sample buffer and the protein samples were
boiled for 5 mm. The recombinant proteins were resolved by SDS-PAGE, using pre-
made Novex (San Diego, CA.) Bis-Tris, Tricine or Tris-Gly minigels according to
standard procedures. Gels were either stained with Coomassie blue or proteins were
transferred to Immobilon PVDF membrane (MilliporeCorp.).
Western and dot blot membranes were blocked with 5% non-fat milk or 2%
BSA Fraction V (Fisher Scientific Co., Pittsburgh, PA.) in phosphate buffered saline,
pH 7.4, with 0.2% tween-20 (PBS-T). Membranes were then incubated with primary50
monoclonal anti-his antibody (1:10000, Clontech, Palo Alto, CA) or 1 0F5 monoclonal
anti-M6 antibody (1:5000) for 2 hr or overnight at40C, or India His-probe (1:2000,
Pierce Chemical Co., Rockford, IL) for 1 hr at room temperature. Blots were washed
3X for 5 mm each with PBS-T with 0.2% BSA. Blots were then incubated in
secondary anti-mouse antibody conjugated to horseradish peroxidase (HRP,
Amersham-Pharmacia Biotech Inc.) for 2 hr at room temperature. Blots were washed
as described above and washed 2X with PBS-T. The blots were developed using HRP
electrochemiluminescence (Pierce Chemical Co.). The developed
electrochemiluminescent film was scanned into Adobe Photoshop and printed on
photo quality paper.
NucA Enzyme Assay
Pico Green (PG, Molecular Probes, Eugene, OR) was diluted 1:400 in 25 mM
Tris-HC1, pH 7.5, and 10 mM CaC12 containing 5 j.tg/ml of heat denatured DNA
(Sigma Chemical Co., St. Louis, MO). DNA was denatured by heating to 100° C for
30 mm and then cooling quickly on ice. The PG/DNA enzyme reaction buffer was
covered with foil and placed at room temperature for at least 5 mm to allow Pico
Green/DNA binding. PG/DNA reaction buffer (175 pi) was added to each well of a
96 well black View Plate (Packard Instrument Co., Inc., Meriden, CT) containing 25
p.1 of either diluted or undiluted cell culture supematant. Fluorescence was read with
an excitation of 480 nm and emission of 520 nm immediately and every 30 or 60 mm
up to 4 hours at 37° C in a Spectrafluor Plus (Tecan US Inc., Durham, NC.). Each 96
well plate had a S. aureus micrococcal nuclease control. The reaction buffer without51
nuclease (Pico GreenIDNA) equals the control. PicoGreen background was
determined using PicoGreen (1:400) alone in reaction buffer without DNA. Nuclease
activity was represented as a percent as indicated by the equation below. Experiments
were performed at least three times with each condition in quadruplicate; data from
one representative experiment are shown. Nuclease activity was calculated using the
following equation.
Nuclease Activity = 100 - % Control
% Control = A
ELISA
e Relative Fluorescence UnitsPicoGreen Back
PicoGreen-DNA Control
X 100
Pre-wetted ELISA plates were coated overnight with 200tl10F5 antibody
(150 ng/ml per well) in carbonate buffer, pH 10. The plates were washed 1X quickly
and 3X for 5 mm each with PBS-T + 0.2% casein and blocked with 2 % casein in
PBS-T for 2 hr or overnight at room temperature. M6 MAC purified protein was
added in a range of 1:1000 to 1:64000 and incubated for 1.5 hr at room temperature or
overnight at 4° C. Plates were washed as above. Rabbit anti-M6 polyclonal detection
antibody 9827, (1:4000) was added and the plates were incubated for 2 hr at room
temperature. Plates were washed again and incubated with anti-rabbit 2° antibody
conjugated to HRP (Amersham-Pharmacia Biotech Inc.) for 2 hr at room temperature.
Plates were washed as above and 3X more with PBS-T. For detection, 50 p.1 of Pierce52
Femto ECL reagent (mixed 1:1 Pierce Chemical Co.) was added to each well. The
plates were read in a Tecan Spectrofluorimeter (Tecan US Inc.) on luminescence.
Results
Cloning of His-Tagged Expression Cassettes
S.gordoniihas been used as a protein expression system for the expression and
secretion of proteins into the culture medium. One reason for this is the development
of S.gordoniistrain GP25 1, which undergoes homologous recombination with
pSMB 104 transfer plasmid (Oggioni and Pozzi, 1996). While the cloning and
expression of proteins in the SPEX system has been reduced to practice for several
types of proteins, the purification of these proteins away from medium components is
currently the foremost practical limitation. In order to simplif' the protein purification
process, a poly-histidine tag was cloned into the SPEX secretion vector at either the N
or C-terminal end of the heterologous protein gene.
DNA coding for either 6 or 10 histidines was cloned in-frame at the N-
terminus or the C-terminus of the S.pyogenesM6 or the S.aureusNucA gene coding
sequences. Each terminal fusion was created in two locations on the SPEX secretion
vector. For the N-terminal clone, one tag was placed at theKpnIsite of the multiple
cloning region (KFIis) and one was placed at the EcoRI site of the multiple cloning
region (EHis) (Figure 3.1A). One C-terminal clone contains a tag inserted just prior to
the LPXTG anchor region with a stop codon to prevent anchoring (H 10). The other
tag is inserted after theHindu!site to produce a truncated protein just after the C-
repeat region of the M6 protein or the NucA protein (TH1O) (Figure 3.1B). All clones53
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Figure 3.1. Histidine tagged constructs. 1A. N-terminal histidine tagged
constructs, EHis and Kills schematic. Four new constructs were made with a 6-
histidine tag at the N-terminus. Two constructs contain the his-tag at the EcoRI site
prior to the NTR (EHis-NucA contains the NTR, while EHis-M6 does not). Two
constructs contain the his-tag at theKpnIsite located after the NTR. The M6
constructs have the stop codon (TAA) located after the D-repeat region (DRR), while
the NucA constructs have a stop codon located just after the NucA gene.
lB. C-terminal histidine constructs, H1O and TH1O schematic. Two new
constructs were made with a 1 0-histidine tag at the C-terminus of the expressed
proteins. The Hl0 construct contains the DRR of the M6 protein with a stop codon
prior to the anchor. The TH 10 construct is truncated and contains the his-tag and stop
codon just after theHindu!site in theziemm6gene. Both the CRR of thezlemm6
gene or the NucA gene were cloned into the H10 and TH1O vectors.54
were verified by restriction enzyme analysis and sequencing (CSL). These new
vectors were transformed into S. gordonii GP25 1 and underwent homologous
recombination to produce eight new S. gordonii strains expressing either M6 or NucA
with N- or C-terminal histidine tags shown in Figure 3.1A and 3.1B. Table 1 shows
all of the features of the various proteins expressed from the new strains. As shown in
the table, EHis M6 does not contain the 16 an N-terminal region (NTR) thought to be
required for efficient signal peptidase cleavage of the 42 an signal peptide.
M6-his or NucA-his expression was verified by a streak blot or by a
metacbromatic assay respectively (data not shown). Positive transformants were then
selected for further study. Expressed and secreted proteins were tested for binding to
and ease of purification over an immobilized metal affinity colunm (MAC) and the
fold purification was calculated. In addition, M6-His immunoreactivity and NucA-His
enzyme activity were also tested on pre and post-MAC samples.
Column Chromatography and Purification
To determine if his-tagged fusion proteins secreted from S. gordonii could be
successfully purified using MAC, culture supernatant from all eight strains was loaded
onto CoCl2 charged sepharose resin. S. gordonii recombinant strains were grown
overnight at370C in BHI. The cultures were centrifuged to remove cells and the
culture supernatant was filtered through a 0.2 m filter. Approximately 10 ml of
culture supernatant was loaded on the CoCl2 colunm. Bound proteins were eluted
using a single step with 1 M imidazole. Analysis of the fractions from the column
showed binding and purification of all eight his-tagged fusion proteins expressed. All
his-tagged fusion proteins had similar elution profiles; proteins eluted with 1 M55
Table 3.1. Features of Constructs
Construct Location of TagFused
to DRR
N-Terminal
16 aa Present
Calculated
Size (kDa)
EHis M6 N-term EcoRI Y N 27
Kilis M6 N-term KpnI Y Y 29
EHis NucA N-term EcoRI N Y 21
KHis NucA N-term Kpni[ N Y 21
NucA&M6-Hl0C-term anchor Y Y 30&29
NucA&M6-TH 10C-term Hindill N Y 18&16
DRR = D repeat region of M6 protein
aaamino acid
imidazole from the column in fractions 5-7 (Figure 3.2, data shown for EHisM6 and
EHisNucA). Additionally, each of the recombinant proteins from fractions 5-7 were
similar in protein concentration according to the absorbance at 280 nm from the
chromatograph (Figure 3.2) and from the Bradford dye protein estimates (Table 2).
For the pre-MAC purified samples, the M6-fusion strains produced an average of 2.87
mg of total protein while the NucA fusion strains produced an average of 4.43 mg of
total protein (Table 2, colunm 1). The highest M6-His producer of total protein was
the C-terminus M6H1O (3.1 mg) and the highest NucA-His producer was the N-
terminus EHis-NucA strain (4.21 mg). This total protein includes secreted proteins
and surface anchored proteins that have been sloughed from the cell wall after
overnight growth. M6-His and NucA-His post-Mac purified strains yielded on
average approximately 32 pg and 41 .ig, respectively, of purified protein (Table 2,
column 2). The EHis-M6 strain and the NucA-TH1O strain produced the highest yield
of purified protein at 34 pg and 49 tg protein, respectively. This yield represents on
average -1% of the total protein from the pre-MAC Bradford dye estimates.mAU
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Figure 3.2. Metal affinity column chromatography profiles of M6 and NucA S.
gordonli culture supernatant. Metal Affinity Column (MAC) chromatography was
performed using an Amersham-Pharmacia AKTApurifier 10/100 FPLC on all of the
M6and NucA his-tagged strains. Ten ml of overnight culture supematant was loaded
on a CoC12 charged column. Bound proteins were eluted with 1 M imidazole. Elution
profiles are shown as absorbance (280, left axis and 254 nm, right axis) over ml eluted
(X-axis). All the culture supematants from the 8 his-tagged strains demonstrated
similar elution profiles with protein eluting in fractions 5-7. Flow rate at lmllmin.
The arrow shows the start of the imidazole elution.57
Table 3.2. Fold Purification of M6 and NucA Recombinant Proteins using Metal
Affinity Chromatography.
Recombinant
Protein
Pre-MAC
Total
Protein (mg)
Post-MAC
Total Protein
(mg)
Pre-MAC
RLU/fmoles
Protein
(1:4000)
Post-MAC
RLU/fmoles
Protein
(1:4000)
Fold
Purific-
ation
(*average)
Ehis-M6 2.85 0.034 2.68 53.56 14
KHis-M6 2.80 0.030 3.12 65.73 22
M6-H10 3.10 0.032 3.99 34.10 8
M6-TH1O 2.74 0.032 3.01 45.59 17
Average 2.87 0.032 3.20 49.75 15.3
Recombinant
Protein
Pre-MAC
Total
Protein (mg)
Post-MAC
Total Protein
(mg)
Pre-MAC
Activity/pmol
Protein#
Post-MAC
Activity/pmo
I Protein#
Fold
Purific-
ation
EHis-NucA 4.21 0.046 0.84±0.004 8.96±0.008 11
KHis-NucA 3.79 0.038 0.90±0.005 10.80±0.023 12
NucA-H10 3.27 0.031 1.34±0.03 18.83±0.087 14
NucA-TH1O 2.92 0.049 1.35±0.004 8.74+0.006 6.5
Average 4.43 0.041 1.11 11.83 10.7
*Fold purification was calculated at all dilutions (1:1000 to 1:16,000) and averaged.
Numbers are shown for 1:4000 dilution only
#Mean ± S.E.
MAC Fraction Analysis
To detennine if the imidazole eluted protein in fractions5-7were his-
immunoreactive, fractions were analyzed using a dot blot. One hundred microliters of
the 1 ml eluted fractions as well as 100 .tl of the pre-column supernatant and flow
were transferred to a well in a 96 well dot blot apparatus containing PVDF membrane.
The membranes were developed using anti-his antibody (1:10,000, Clontech) and his-
immunoreactive fractions identified by HRP chemiluminescence using an anti-mouse-
HRP conjugated secondary antibody. Blots were developed using Pierce Femto ECL
reagent. All eight strains showed his-immunoreactivity in fractions5-7with the
strongest immunoreactivity in fraction 6 (Figure 3.3, data shown for KHis-M6 and
NucA, and M6 and NucA-H10). The pre-colunm supematant (lane P) was also his-KHis-M6
M6-H1O
KHis-NucA
NucA-Hi 0
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Figure 3.3. Dot blots of MAC fractions using anti-his antibody. Shown are the
pre-MAC supernatant (P) and elution fractions 1-10 from the MAC chromatography.
All 8 his-tagged fusions proteins demonstrated similar elution profiles. His-
immunoreactive protein eluted between fractions 5 and 7 with most of the his-
immunoreactive protein eluting at fraction 6. Data shown for four strains only (KHis-
M6 & NucA, M6 & NucA-H10). Fflowthrough.59
immunoreactive, but the flow (lane F) did not display his-immunoreactivity. A non-
transformed control strain (GP251) was negative for his-immunoreactivity (data not
shown).
Molecular Weight Analysis
To determine if the inimunoreactive dot blot fractions contained his-tagged
proteins of the appropriate molecular weight for M6 and NucA, the immunoreactive
fractions were separated on 4-12% BisTris SDS-polyacrylamide gels and proteins
transferred to PVDF membrane. The membranes were exposed to either anti-his
antibody (1:10,000, Clontech) or India-His-Probe (1:2000, Pierce). The recombinant
M6 proteins were also run separately and exposed to M6 monoclonal 1 0F5 antibody
(1:5000). Blots were developed using standard ECL reagents as described in the
methods section.
All MAC purified his-tagged proteins appeared to have his-immunoreactive
proteins at the appropriate molecular weights (Figure 3.4). E and KHis-M6
immunoreactive proteins were detected at approximately 27 and 29 kDa, respectively.
In addition, KHisM6 had a second band at approximately 27 kDa (Figure 3.4, arrow).
This species has not yet been characterized, but seems to correspond to the size of
EHis-M6, suggesting that the NTR may have been cleaved or degraded. Further study
is needed to conclude this. M6H1O and M6TH1O had immunoreactive bands at
approximately 29 and 16 kDa, respectively. A western blot using M6 antibody 1 0F5
showed similar results (data not shown). E and KHisNucA had bands at
approximately 21 kDa and NucAH1O and NucATH1O had his-immunoreactive bandsE
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Figure 3.4. Western blots of post-MAC fraction 6 using anti-his antibody. Fifteen
microliters of fraction 6 from the 8 MAC purified fusion proteins were resolved by
SDS-PAGE. The proteins were transferred to membrane and probed with anti-his
antibody. The KHis-M6 fusion protein was resolved as two bands, at 29 and -27
kDa. The 27 kDa band is indicative of a fusion protein lacking the 16a.a NTR (arrow).
All other his-tagged proteins resolved at the expected size.at approximately 30 and 18 kDa, respectively (Figure 3.4). A western blot using the
India His-probe showed similar results for both the M6 and NucA-his tagged proteins
(data not shown).
Nuclease Enzyme Assay
An enzyme assay for the NucA his-tagged proteins was performed to
determine if the nuclease retains its enzyme activity after MAC purification and to
determine the fold purification of the NucA his-tagged fusion proteins. All four NucA
recombinant proteins demonstrated nuclease activity after purification (Figure 3.5).
Figure 3.5 shows the enzyme activity in both the crude culture supernatant and the
MAC purified fraction. MAC purified fraction 6 from all NucA his-tagged fusions
demonstrated greater nuclease activity/Lg protein as compared to the pre-MAC
supernatants (Figure 3.5). To determine fold purification of the MAC purified NucA
his-tagged proteins, the nuclease enzyme activity/tg protein was compared between
the pre-MAC culture supernatant and the post-MAC purified fraction number 6. The
NucAH1O fusion protein showed the greatest fold purification at 14-fold while the
NucATH1O fusion had the lowest fold purification at 6.5 fold (Table 2, Figure 3.5).
M6 ELISA
To determine the fold purification of the His-tagged M6 fusion proteins, a
capture ELISA was performed. Culture supernatants and purified protein from
fraction 6 were diluted 1:1000 to 1:64000 and M6 protein was captured on a 96 well
ELISA plate coated with 1 0F5 anti-M6 antibody. Captured protein was detected using
an anti-M6 polyclonal antibody (1:4000) and a secondary anti-rabbit-HRP conjugated-
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Figure 3.5. Enzymatic assay of NucA constructs before and after MAC
purification. Nuclease activity was estimated for the culture supematant and the post-
MAC fraction 6. Results were plotted as NucA activity/pmoles protein. NucAH1O
had the most post-MAC activity/pmoles of protein. Bars = mean + S.E.63
antibody (1:10,000). The ELISA plate was read in a Tecan spectrofluorimeter using
luminescence. Figure 3.6 shows a graph of the M6 ELISA comparing the relative
luminescence/fmole protein from both pre and post-MAC purified samples. All the
post-MAC purified samples had a greater relative luminescence/fmole protein as
compared to the pre-MAC purified samples (Figure 3.6). The ELISA demonstrated an
average 15-fold purification of M6-His fusion protein using MAC (Table 2). The
KHis-M6 fusion demonstrated the greatest fold purification at 22-fold with the
M6H1O fusion showing the lowest fold purification at 8-fold.
Discussion
DNA coding for the recombinant M protein (Aemm6) of Streptococcus
pyogeneshas been expressed in the prototype plasmid (pSMB 104) used in a variety of
studies in our laboratory. The reasons are that it is easy to express, reacts with highly
specific antibodies, and is being used in some ongoing vaccine studies. One question
in this study was whether the recombinant M protein, being a helical rod (Phillips et
al., 1981), could be easily purified using MAC after the addition of a poly-histidine
tag. A possibility existed that the histidine tag would not bind to the column due to
the secondary structure of the M6 protein. Varying the size of the poly-histidine tag (6
to 10 histidines), the location of the tag within the fusion protein (N or C-terminal), or
finally the expressed fusion protein itself (M6 or NucA) would help determine
whether MAC purification of the M6-his fusion protein is feasible.
After cloning all of the variations of the histidine tagged recombinant proteins
(Figure 3.1) and performing expression and purification studies, we found that any1o0
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Figure 3.6. ELISA analysis of M6-his tagged proteins before and after MAC
purification. Capture ELISAs were performed on samples diluted from 1:1000 to
1:64,000 (X-axis). M6 protein was captured using a monoclonal antibody directed
against the CRR of the M6 protein and detected using ECL. Data were plotted as the
relative luminescence units/fmoles protein. All post-MAC samples demonstrated an
increase in RLU/fmoles protein compared to culture supematant with the Khis fusion
showing the largest increase (open circle). The increase in luminescence between the
pre and post-MAC samples was used to determine foldpurification. Data shown for
1:1000 to 1:16,000 dilutions only.configuration that we chose was able to bind and elute from the column. Each fusion
protein was almost identical in its purification profile (Figure 3.2) indicating that the
difference in structure between the CRR of M6 and the NucA protein does not affect
binding or purification. Further, the placement of the Histidine tag on either the N or
C-terminus of the fusion protein also had no detrimental expression or purification
effects as shown by the protein concentrations post-MAC in Table 2 and by the
presence of all of the proteins in the western blot of the post-MAC fractions (Figure
3.4). The western blot does show a difference in intensity of the full length H 10
(especially NucAH1O). Though the blot is not meant to be quantitative, equal amounts
of post-MAC fraction was loaded. Those fractions were quantified and found to have
roughly equal amounts of protein (Table 2). Perhaps the difference in intensity has to
do with the accessibility of the histidine tag to the metal probe after purification.
Truncation to remove the D-repeat region of the M6 protein that would not be
desired in a heterologous fusion, does not seem to affect either expression or
purification of the protein. However, the activity of the NucA truncated fusions were
lower on a per molecule basis than the fusion that contained the D-repeat region
(Figure 3.5), suggesting that the extra region somehow enhances the normal activity of
the enzyme. This region may have a stabilizing effect on the enzyme. The activity of
the NucA enzyme expressed using SPEX is an indication that this system could be
useful in expressing and purifying other biologically active proteins.
The binding activity of the M6-his fusions by ELISA were somewhat different
after purification of the fusions (Figure 3.6) suggesting that placement of the histidine
tag may have an effect on folding that was not expected. The C-terminal histidine tagon the full length construction (M6H1O) showed a flatter binding profile than the other
proteins, suggesting that its binding affinity to the 1 0F5 antibody was decreased. The
overall amount of protein purified off the column was equivalent to the other M6-his
fusions according to the post-MAC calculations in Table 2. It raises the question of
whether the C-terminal histidine tag after the D-repeat region of M6 causes the protein
to fold on itself in a way that makes the CRR of M6 inaccessible to the 1 0F5 antibody.
The truncated C-terminal fusion binding to 1 0F5 does not appear to be affected by the
placement of the tag.
This work has shown that the SPEX system can be used not only to secrete
proteins into the medium, but that the expressed proteins can display histidine affinity
tags on either terminus of the protein and be efficiently purified under native
conditions. This further illustrates the utility of this system for the expression and
purification of a variety of proteins. Like all expression systems however, SPEX has
to be refined for the individual requirements of the particular protein being expressed.
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Abstract
A Gram-positive bacterial expression vector has been developed for the
expression and secretion or cell wall surface anchoring of heterologous proteins using
Streptococcus gordonii. This system, termed the Surface Protein Expression system
or SPEX, has been used to express a variety of surface anchored or secreted
heterologous proteins. In this study, the Mxe GyrA intein and chitin binding domain
fusion from New England Biolabs was used in conjunction with the SPEX system to
express a fusion protein for secretion, cleavage, and purification. Using this strategy,
Streptococcus gordonii was transformed to express a fusion protein consisting of a
target antigen fused on its C-terminus to an intein cleavage domain and chitin binding
domain. Two target antigens, the C-repeat region from Streptococcus pyogenes M6
protein and the nuclease A enzyme of Staphylococcus aureus were expressed as
fusions and tested for intein cleavage. In this study, the target fusion protein that is
secreted into the medium is purified by binding to chitin beads and then subjected to
reaction conditions to elicit endoproteolysis and release the target protein from the
cleavage and purification domains. The M6 and nuclease A fusions were shown to
bind the chitin beads, and elute under cleavage reaction conditions. In addition,
nuclease A fused to the cleavage domain demonstrated activity both as a fusion
protein and after cleavage. Taken together, these data suggest that the hybrid SPEX-
Intein system is useful in expression and downstream purification of heterologous
proteins.73
Introduction
Streptococcus gordonii (S. gordonii) has been used as a Gram-positive
bacterial expression vector for the Surface Protein Expression (SPEX) system, which
is used to express both surface anchored and secreted proteins (Dutton et al., 2000;
Myscofski and Hruby, 1998). The bacterium uses a highly conserved pathway of
protein targeting and anchoring among Gram positive bacterial species (Fischetti et
al., 1990; Navarre and Schneewind, 1999; Schneewind etal., 1992). Gram-positive
bacteria target proteins to the cell wall using an N-terminal signal sequence that is
cleaved at the cell wall. Surface proteins are shuttled through the newly made cell
wall at the septum of the dividing bacterium, and become anchored if they contain a
specific highly conserved C-terminal anchor motif. The anchor motif consists of a
LPXTG anchor followed by a hydrophobic region and charged tail at the C-terminus
(Fischetti etal., 1990; Schneewind et al., 1992). The mechanism for anchoring has
been recently reviewed (Navarre and Schneewind, 1999). Additionally, this bacterium
is used to secrete proteins. In order to secrete proteins, the DNA that codes for the
protein is changed by inserting a stop codon prior to the anchor (Myscofski and
Hruby, 1998). The expression of heterologous proteins relies on a homologous
recombination event to insert the target heterologous gene from a plasmid containing
genomic flanks into the genome of S. gordonii strain GP25 1. Once recombined, the
bacterium expresses the heterologous gene either on its surface if the anchor is present
or secreted into the medium if the anchor is not appended.
SPEX has been developed both to anchor heterologous proteins to the bacterial
surface for live bacterial vaccine vector studies (Medaglini et al., 1995; Pozzi et al.,74
1994; Sharma et al., 1996) and secrete heterologous proteins for purification and use
in the laboratory (Dutton etal., 2000; Myscofski and Hruby, 1998). Active enzymes
have been expressed and secreted using this system (Dutton et al., 2000), as well as
subunit vaccine candidates (Bessen and Fischetti, 1988; Bessen and Fischetti, 1990;
Bronze etal., 1992).
In order to purif' the secreted heterologous protein away from contaminating
medium components, a variety of purification tags and fusions can be made.
Previously, it was shown that histidine tags fused to either the N or the C-terminus of
the protein allowed for efficient purification using immobilized metal affinity
chromatography (Myscofski et al., 2000). The drawback with this specific method is
that the histidine tag remains on the fusion protein after purification. Histidine tags
are thought to be innocuous, and they are not believed to interfere with downstream
functions of the protein, but there may be subtle changes in protein folding that in turn
change the affinity of the heterologous protein for specific antibodies or substrates
when the tag is placed in certain configurations (Myscofski et al., 2000).
Additionally, regulatory agencies may be reluctant to accept vaccine candidates with
added epitopes that are not directly involved in the immunization therapy. To address
this problem, cleavage options were considered for inclusion in the downstream
purification protocol.
Some cleavage options include the use of the tobacco etch virus (TEV)
protease cleavage site (Parks et al., 1994) or the factor Xa cleavage site (Magnusson et
al., 1975). These cleavage sites allow for the addition of proteases, specifically TEV
protease or factor Xa, respectively after the purification step. Then the proteases can75
be purified away from the target protein using another round of purification. The pure
protein can then be used in downstream studies. The limitation here is that there are
usually a few remaining amino acids from the cleavage site itself, which can defeat the
purpose of cleaving a small fusion tag. Additionally, the extra purification steps
required to remove the protease can result in loss of target protein.
Another option available for efficient purification is the use of an intein
cleavage domain and a purification domain at either the N or the C-terminus of the
target protein (Chong etal., 1996; Chong et al., 1998; Chong and Xu, 1997). The
addition of these domains allows for the purification and cleavage of the target protein
away from the purification tag. In addition, intein cleavage can remove all fused
amino acids from the target protein if N-terminal intein cleavage is used, or cleave all
but a cysteine if C-terminal intein cleavage is used. After purification, the protein is
virtually free of contaminating intein and purification domains.
Inteins (internal proteins) are self-splicing proteins that remove themselves
from within an extein (external protein), and religate the newly cleaved ends of the
extein together (Perler etal., 1994). There are over 100 known naturally occurring
inteins from many different organisms, all of which share some evolutionary structure
or function (Perler, 1998; Mathys etal., 1999). Many larger inteins contain a nuclease
function while mini-inteins do not (Perler etal., 1997). Inteins are often found within
exteins that function as polymerases or metabolic enzymes (Perler et al., 1997). In the
intein cleavage system developed by New England Biolabs (NEB), mutations were
created at either the N or C-terminal cleavage site of an intein. This results in an
intein that cleaves on the unadulterated cleavage site in the presence of either a thiol76
donor (N-terminal cleavage), or with some inteins, in lower pH or lower temperature
conditions (C-terminal cleavage) (Mathys etal., 1999). The result is a system that can
be used to purify a fusion protein away from contaminating cell or medium
components and later cleave the purified target protein under controlled conditions.
The intein chosen for expression using the SPEX system is the Mycobacterium
xenopi (Me) GyrA intein (Evans etal., 1998) along with the Bacillus circulans chitin
binding domain (CBD) (Watanabe et al., 1994) (NEB, Beverly, MA). The Mxe GyrA
gene is a 594 bp gene that codes for a mini intein of about 22 kDa (Mathys etal.,
1999), which is smaller than many other inteins and may, as a result of size, be more
easily expressed in heterologous expression systems. The CBD is a 156 bp gene
fragment coding for a 5 kDa domain that binds tightly and specifically to chitin beads
(Watanabe etal., 1994).
The mechanism by which inteins cleave themselves from within the extein has
been extensively reviewed (Perler et al., 1997). N-terminal intein cleavage requires an
N-S (cysteine) or an N-O (serine) acyl rearrangement to create an ester linkage
between the N-terminal extein and the intein. At this point, the junction at the C-
terminus of the intein would assist in the N-terminal cleavage and transesterification
reaction. A mutation of the reactive residues at the C-terminus of the intein that are
required for cleavage and the addition of a thiol donor (like dithiothreitol or cysteine)
to catalyze the nucleophilic attack at the N-terminus is the basis for the N-terminal
cleavage of engineered fusion proteins (Chong et al., 1997).
However, if the target protein were fused to the C-terminus of the intein, then
C-terminal intein cleavage would be required. To artificially create a cleavage of the77
C-terminus of the intein in the absence of N-terminal cleavage, the reactive N-terminal
sites have been changed (removing the cyteine or serine residues), and a pH and
temperature dependent cleavage reaction would occur at the C-terminus (Mathys et
al., 1999).
In this study, the target protein is N-terminal to the inteinlCBD fusion,
requiring N-terminal intein cleavage. The Mxe intein and CBD sequences were
introduced into the pSMB 104 plasmid downstream of the C-repeat region (CRR) of
the M6 gene. This CRR is the target protein to be purified, and the specific Mxe intein
construct cleaves on its own N-terminus just downstream of the expressed protein,
leaving the purified CRR domain after purification and cleavage. Additional cloning
was performed to replace the CRR with the Staphylococcus aureus (S. aureus)
Nuclease A gene. After transformation of the new plasmids into S. gordonii,
recombinant strains were isolated. Purification and cleavage studies were performed
on those strains. Both strains expressed the heterologous fusion proteins (M6XCBD
or NucAXCBD). Both fusions demonstrated immunoreactivity with the Mxe intein
antibody. The NucA strain demonstrated enzyme activity in both its fusion form and
its cleaved form. M6 demonstrated a shift in size on a western blot of the purified
fractions with CRR specific antibodies. The results of this study demonstrate that the
SPEX system can express and secrete heterologous intein fusion proteins, which can
be purified by binding to chitin beads and cleaved to remove the unwanted domains.78
Materials and Methods
Bacterial Strains, Plasmids, and Media
Escherichia coli DH5a cells were grown in Luria Bertani (LB) broth or on LB
agar (Difco, Detroit, MI) containing 1.5% agar with the appropriate antibiotics. S.
gordonii strain GP251 is the recipient strain for the introduction of plasmids
containing foreign genes. GP25 1 cells were grown in brain-heart infusion (BHI,
Difco) broth or on BHI agar plates. The parent recombination plasmid pSMB 104, a
derivative of pSMB55, (Oggioni and Pozzi, 1996) is a 5.66 Kb plasmid that does not
replicate in S. gordonii. Strain GP25 1 contains the chioramphenicol acetyltransferase
(CAT) gene artificially inserted into the genome of wild type S. gordonii (Challis
strain) as previously described (Oggioni and Pozzi, 1996). The CAT gene is flanked
by sites of homology with the pSMB 104 plasmid, and is recombined out of the
genome after successful transformation with pSMB 104. GP251 pSMB 104 encodes
emm6AlO4, which contains the signal peptide, the first 16 N-terminal and last 220 C-
terminal amino acids of the M6 protein. Flanking the M6 gene and an erythromycin
resistance gene is a region of DNA homologous to the DNA surrounding the CAT
gene in the S. gordonii GP25 1 genome.
Recombinant Cloning
All PCR and sequencing primers were ordered from Gibco BRL (Rockville, MD).
The insertion of the Mycobacterium xenopi (Mxe) GyrA gene fused to the chitin
binding domain (CBD) of Bacillus Circulans into the M6 gene in pSMB 104 was the
method used to construct pM6XB. PCR primers 5INT (5'GGGAAAAAGCTTTA-79
CTCGAGGGCTGCATCACGGGAGATG3') and 3CBD (5 'CCTCCTAAAGCTTA-
TCATTGAAGCTGCCA3') were used to amplify the Mxe GyrAICBD fragment from
the plasmid pTXB1 (Evans et al., 1998) (generously provided by New England
Biolabs, Beverly, MA). This resulted in a fragment that contained a Hindu! site
followed immediately by a X7ioI site and the intien/CBD fusion followed by a stop
codon and a second Hindu! site. The fragment was digested with HindIII and ligated
to pSMB 104 that was digested with Hindu! and incubated with calf intestinal
phosphatase to remove the 5' phosphates (Boehringer Mannheim, Indianapolis, IN).
This Hind!!! site in pSMB 104 is found immediately downstream of the C-repeat
region (CRR) of the M6 protein gene. The plasmid was transformed into DH5a cells
and plated on LB plates with 100 tg/ml ampicillin.
For the NucA constructs, the NucA gene was cloned from pVE5232 (generously
provided by Dr. Jean-Christophe Piard) as previously described (Myscofski et al.,
2000) except that the 3' XhoI site was placed in frame with NucA after additional
PCR. The NucA gene was inserted into the KpnI and XhoI sites in the new pM6XB
vector, after removal of the CRR of M6, and named pNUCXB.
Bacterial Transformation
Frozen stocks of naturally competent S. gordonii GP25 1 cells were prepared
and transformed as described (Pozzi et al., 1990). The frozen cells were thawed at 37°
C and 0.5 p.g of the newly cloned plasmids was added. The cells were incubated at
37° C for 45 mm and then plated onto multilayer plates as described previously (Pozzi,
1987). Putative transformants were picked from the multilayer plates as previously80
described (Myscofski and Hruby, 1998). For selection of S. gordonii recombinant M6
strains, streak blots were performed as described previously (Pozzi, 1987). For
selection of NucA strains, NucA expression was detected using a metacbromatic agar
diffusion assay as described (Lachicaetal.,1971). The non-transformed recipient
strain GP25 1 was used as a negative control for protein expression.
Intein Cleavage Assay
Cleavage assays were performed on overnight cultures of the newly
transformed strains (Mathyset al.,1999). Ten milliliters of supernatant from
overnight cultures were added to 1.5 ml of washed chitin beads (NEB) and 10 ml
column buffer containing 30 mM hepes and 0.5 M NaCl in a 50 ml polypropylene
tube. The protein was incubated at 4°C for 6 hours with continuous rotation to
promote binding using a batch purification method. The chitin beads were pelleted by
centrifugation at 3,000 X g for 10 minutes. The "flowthrough" was removed and the
beads were washed 2 X with colunm buffer and again centrifuged. The wash was
removed and the beads were divided equally and placed in two 1.5 ml microfuge
tubes. Five hundred microliters of column buffer was added to both tubes. DT1' (1 M
stock solution made fresh) was added to one tube to a final concentration of 50 mM.
The second tube was used as a non-cleavage control. Both tubes were incubated
overnight at 16°C, then centrifuged at 8,000 X g for 1 minute. The supernatants were
removed and the beads were stripped 2 X with 500 p.l column buffer containing 1%
SDS, the stripping buffer was removed and saved for further analysis. All of the
fractions were analyzed by SDS-Page, immunoblot analysis, and a nuclease A enzyme81
assay. Protein concentration estimates on the fractions were performed according to
manufacturer's instructions using Bradford reagent (BioRad Laboratories, Hercules,
CA).
SDS-Page and Immunoblots of Cleavage Fractions
Fifteen microliters of each fraction from the cleavage assay was mixed with 5tl4
X SDS sample buffer and boiled for 3 minutes. The proteins were resolved by
discontinuous gel electrophoresis (SDS-PAGE), utilizing 13% tricine polyacrylamide
gels as described previously (Schagger and von Jagow, 1987). The gels were then
subjected to immunoblot analysis (Towbin et al., 1979) by blotting to nitrocellulose
membrane. The membranes were blocked with 3% gelatin in tris buffered saline
(TBS) pH 7.4, then washed in TBS containing 0.05% tween (TTBS). The membranes
were then incubated with 10F5 monoclonal antibody (1:2000) specific for the CRR of
M6 (Jones etal., 1986), or polyclonal anti-iVfre intein antibody (1 :5,000) (NEB) in
TTBS with 1% gelatin overnight at room temperature. Blots were then washed 3 X
with TTBS and incubated for 2 hours with secondary anti-mouse or anti-rabbit
antibody conjugated to alkaline phosphatase (BioRad). Blots were washed and
developed using BioRad reagents according to manufacturer's instructions. Blots were
dried and scanned into Adobe Photoshop and printed on photo quality paper.
Nuclease A Enzyme Assay
Assays were performed as described previously (Dutton et al., 2000). Briefly,
Pico Green (PG, Molecular Probes, Eugene, OR) was diluted in reaction buffer
containing 5 pg/m1 of heat denatured DNA (Sigma Chemical Co., St. Louis, MO).82
PG/DNA reaction buffer (175j.tl)was added to each well of a 96 well black View
Plate (Packard Instrument Co., Inc., Meriden, CT) containing 25j.tlof diluted cleavage
fraction supematant. Fluorescence was read with an excitation of 480 nm and
emission of 535 nm immediately and every 30 or 60 mm up to 4 hours at 37° C in a
Spectrafluor Plus (Tecan US Inc., Durham, NC.). Each plate contained a S. aureus
micrococcal nuclease positive control. The reaction buffer without nuclease (Pico
Green/DNA) equals the negative control. PicoGreen and reaction buffer alone was
used to determine background. Nuclease activity was calculated as a percentage
(Dutton et al., 2000).
Results
Cloning of Inteins, Expression and Cleavage
The DNA coding for the inteinlCBD fusion was cloned from pTXB 1 (NEB)
into the plasmid pSMB 104, sequenced and transformed into S. gordonii. Figure 4.1A
shows a schematic of the new construct (either pM6XB or pNUCXB) and the sites
used for cloning. The resulting protein, after cleavage of the signal sequence at the
cell wall, includes the first 16 amino acids of the N-terminal region along with the
target protein (CRR or NucA) and the intein/CBD fusion (Figure 4.1B). The S.
gordonii M6 recombinants were screened for expression of the CRR of M6 using a
streak blot, and several positive recombinants were obtained (data not shown). NucA
recombinants were screened for NucA activity using a metachromatic assay and were
screened for the expression of the Mxe intein using a streak blot (data not shown).
One positive recombinant from each construct was grown overnight in BHI. The83
A. Recombinant Plasmid
MCS XhoI and HindlII
KpnI HindIII and Stop
B. Secreted Protein
Cleavage
Site
Chitin
Binding
Domain
Figure 4.1. Intein constructs. 1A. Schematic of the recombinant plasmid.
Plasmid pSMB 104 was used to construct the new vectors (pM6XB or pNUCXB)
containing the target gene (C-repeat region of M6 or NucA) and the inteinlchitin
binding domain. A stop codon (TAA) was inserted after the chitin binding domain
gene. The restriction enzymes used for cloning are shown. MCS,multiple cloning
site.
Figure lB. Schematic of the secreted heterologous fusion protein. The fusion
protein is shown as it would be secreted into the medium. The position where
cleavage occurs in the presence of DTT is shown at the arrow. After cleavage, only
the target protein is released.84
bacterial supernatant containing the secreted fusion protein was removed and used in
cleavage studies.
Intein cleavage assays were performed on the expressed proteins in the
supernatant. The protein in the supernatant was incubated with chitin beads for -6
hours, washed, then the protein was cleaved overnight. Each fraction was saved for
further analyses. Figure 4.2 shows a schematic of the steps taken to cleave the
heterologous fusion proteins expressed in this study. An additional step not shown in
Figure 4.2 is the stripping of the chitin beads using 1% SDS. This step was performed
in order to determine the presence of uncleaved protein still associated with the beads
in both fractions. Total protein in the fractions was quantitated using a Bradford
assay. The results of the cleavage assays are shown using immunoblot analysis and
NucA activity assay.
SDS-Page and Immunoblots
To determine whether the fused intein and chitin binding domains
exhibited cleavage and binding, all assay fractions were separated on SDS-
polyacrylamide gels and subjected to further analysis. An inimunoblot analysis was
performed on the M6 fractions (Figure 4.3) with a CRR specific antibody to detect the
fusion protein prior to cleavage and to assess any shift in mobility of the M6 protein
after cleavage. Figure 4.3, lane 2 shows the protein in the supernatant, and lane 3
shows the flowthrough. The top band of the M6 fusion is shown migrating at 46 kDa,
which is the size expected for that fusion (Figure 4.3, lane 2). Lane 4 shows the wash
fraction and lane 5 shows a cleavage product, for the M6 blot, purified CRR. Notice85
Step 1 Step 2
Grow Bacteria 0/N Mix Supernatant
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.' Supernatant Bind for Several Hours
Step 3
Wash Chitin Beads _______
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Figure 4.2. Steps taken to purify and cleave an intein fusion protein. The bacteria
expressing the recombinant fusion protein are grown overnight in medium (step 1).
The cells are pelleted and the supernatant is added to chitin beads for binding (step 2).
The bound protein/bead mixture is washed (step 3) to remove the contaminating
medium components and then divided into two tubes (step 4). Fifty millimolar DII
in column buffer is added to one tube, colunm buffer alone is added to the other. The
cleavage reaction proceeds overnight at 16°C in the tube that contains DTT.46kDa TIUL
30 kDa
21 kDa
14 kDa :
1 2
86
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Figure 4.3. Western blot of all cleavage assay fractions from the M6 fusion.
Fifteen microliters of each cleavage fraction were resolved by SDS-PAGE. The
proteins were transferred to membrane and probed with anti C-repeat region antibody.
Lane 1, low molecular weight marker; lane 2, overnight supernatant; lane 3,
flowthrough; lane 4, wash; lane 5, +DTT elution; lane 6, -DTT elution; and lane 7,
purified M6 control. Both the cleaved and uncleaved proteins migrate at the expected
molecular weight.87
the difference in the size of the cleaved M6 (16 kDa) versus the M6 fusion in the
supernatant (lane 2) (46 kDa). Arrows show the location of both the uncleaved fusion
and the cleaved CRR. Lane 6 is the uncleaved fraction, which is absent any
immunoreactive protein, and lane 7 contains purified M6 control (Figure 4.3). The
results from the M6 immunoblot show that cleavage occurs after an overnight
exposure to DTT, versus the uncleaved fraction that was not exposed (lanes 5 and 6,
respectively). Additionally, the presence of product in lane 5 shows binding to the
chitin beads occurred because an extensive washing step was performed prior to
cleavage, which would have removed any unbound protein.
An immunoblot was performed on the NucA fractions (Figure 4.4) using aMxe
intein antibody that would be specific for the uncleaved fusions. NucA does not have
a corresponding antibody that is highly specific, so only the uncleaved fusion is
detected with theMxeantibody. The NucA fusion migrates at about 48 kDa (Figure
4.4, lane 2). The fusion that is represented by the top band in lane 2 is absent from
lane 3, which indicates binding of that fusion protein to the chitin beads. There is the
presence of some faster migrating proteins in both lane 2 and 3 (Figure 4.4), indicating
some possible uncontrolled cleavage or breakdown of the fusion protein. The NucA
immunoblot will not show the cleavage product (lane 5, Figure 4.4) because the
inimunoreactiveMxeintein is still associated with the chitin beads. Lane 6 shows the
uncleaved fraction, which is void of any detectable product. Lanes 7 through 10 of the
NucA immunoblot (Figure 4.4) are two SDS stripping reactions that were performed
on the beads after overnight cleavage to remove any fusion protein that was still bound
and determine how much of that protein was not cleaved. Lane 7 and 9 (Figure 4.4)88
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Figure 4.4. Western blot of all cleavage assay fractions from the NucA fusion.
Fifteen microliters of each cleavage fraction were resolved by SDS-PAGE. The
proteins were transferred to membrane and probed with antiMXEintein antibody.
Lane 1, low molecular weight marker; lane 2, overnight supernatant; lane 3,
flowthrough; lane 4, wash; lane 5, +DTT elution; lane 6, -DTT elution. Two SDS
stripping steps were performed on the beads after elution. Lane7,strip 1 of +DTT;
lane 8, strip 1 ofDTT; lane 9, strip 2 of +DTT; and lane 10, strip 2 ofDTT tube.
The top arrow shows the uncleaved fusion at the expected molecular weight (lanes 1,
8, and 10), the bottom arrow shows the expected cleaved Mxe fusion protein (lanes7
and 9). The cleaved NucA protein will not be detected using this method.88
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Figure 4.4. Western blot of all cleavage assay fractions from the NucA fusion.
Fifteen microliters of each cleavage fraction were resolved by SDS-PAGE. The
proteins were transferred to membrane and probed with antiMXEintein antibody.
Lane 1, low molecular weight marker; lane 2, overnight supernatant; lane 3,
flowthrough; lane 4, wash; lane 5, +DTT elution; lane 6, -DTT elution. Two SDS
stripping steps were performed on the beads after elution. Lane7,strip 1 of +DTT;
lane 8, strip 1 ofDTT; lane 9, strip 2 of +DTT; and lane 10, strip 2 ofDTT tube.
The top arrow shows the uncleaved fusion at the expected molecular weight (lanes 1,
8, and 10), the bottom arrow shows the expected cleaved Mxe fusion protein (lanes7
and 9). The cleaved NucA protein will not be detected using this method.89
contain very little of the uncleaved fusion, but lane 8 and 10 do contain the fusion,
which is expected. The top arrow highlights where the uncleaved fusion should
migrate, and the bottom arrow highlights where the Mxe intein/CBD fusion should
migrate after cleavage. To attempt to determine the presence of the NucA protein in
the cleaved fraction as well as assay for active protein in all fractions, a NucA activity
assay was developed (Dutton et al., 2000).
Nuclease A Activity Assay
To determine the presence of active protein in all fractions, a NucA assay was
performed on the NucA cleavage assay fractions. The activity data from this assay
was divided by the amount of protein detected in the Bradford assay, and multiplied
by the estimated molecular weight of each protein. The resulting data is reported in
activity per picomoles of protein. Figure4.5shows the results of the NucA activity
assay. The protein in the supematant and the flowthrough fractions displayed NucA
activity as a fusion to the intein and CBD. The large amount of activity in the
flowthrough shows that the binding of the NucA fusion to the beads was not very
efficient. No enzyme activity was seen in the wash fraction. NucA activity was
present in the + DTT lane, which should contain the cleaved form of the protein that
was released from the fusion protein after overnight treatment. This lane contained
the highest amount of activity/picomole of protein. NucA activity was not present in
the -DTT lane, presumably because the target protein was not released from the fusion
protein bound to the chitin beads (Figure4.5).A small amount of activity was found
in the SDS strip fractions. There was activity in both the +DTT and the -DTT91
fractions (Figure 4.5, last 4 columns) indicating that some of the protein was not
cleaved.
Discussion
In this study, we have demonstrated that we could clone a gene that expresses a
target protein fused to an intein and CBD into our prototype plasmid. We verified
expression of the fusion proteins in S. gordonii. In addition, we have shown that the
fusion proteins can be purified away from the contaminating medium components and
cleaved by the intein to free the target protein under specific conditions.
The results of the western blots of the cleavage reactions demonstrate that
cleavage does take place (Figure 4.3). There is a definite presence of a shift in the size
of M6 where it is expected to be in the cleaved fraction (lane 5). The presence of a
small amount of unbound protein in the "flowthrough" lane is something that may
require further optimization.
The enzyme activity results combined with the western blot using theMxe
antibody show that NucA is present in the + DTT fraction but not the - DTT fraction.
Because there was no fusion protein detected in the immunoblot of either the + DTT
or the -DTT fractions (Figure 4.4), the enzyme activity data (Figure 4.5, +D1'T
column) shows that a cleavage reaction has occurred in the + DTT fraction to free the
enzyme from the intein and the CBD which is still associated with the chitin beads. In
the uncleaved fraction, no enzyme was detected, which indicates that the cleavage
reaction did not occur in that fraction and the fusion is still associated with the chitin92
beads. Thus, cleavage between the active NucA peptide and the immunoreactive
intein must have occurred after exposure to DTT.
The NucA fusion demonstrates activity in both the supernatant and the purified
cleaved fraction, suggesting that both the fusion and the cleaved purified subunit are
active (Figure 4.5). The activity in the flowthrough indicates that there is not efficient
binding to the chitin beads. This may be due to the protein that appeared to be
migrating faster on the gel and could be breakdown products of the fusion protein.
This product will need further characterization, and the method may also need to be
optimized for this particular protein. There is a presence of active NucA in the
stripped fractions.This result may indicate that some of the bound protein is not
cleaved after overnight incubation with DTT.
The benefit of creating this fusion protein is the production of purified protein
with a minimum of post-expression manipulations. Using the chitin beads, there is no
need for expensive protein purification equipment. After binding the proteins,
proteins can be cleaved to remove the unwanted purification domain overnight in the
presence of a thiol donor. One limitation is that the assay does take several hours, but
it is done in the absence of complicated washing and elution steps.
Future experiments are required in order to determine whether an intein fusion
using C-terminal cleavage is appropriate or necessary in this specific system. The
proteins produced using the current SPEX system usually express 16 amino acids of
an N-terminal region of the M6 protein. These may be required for efficient cleavage
of the signal sequence, which targets the protein to the cell wall, but may be
deleterious to the mature heterologous protein. If antigens or enzymes are expressed93
using this system, their activity or specificity may rely on being free of extraneous
amino acids. Creating a fusion by placing the CBD/intein fusion (C-terminal
cleavage) between the 16 N-terminal amino acids and the target protein might be the
next step in the development of a versatile expression system.
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Discussion
Goals of this study:
The overall goal of this study was to create a versatile protein expression
system for the expression, secretion, and purification of proteins for laboratory use.
The specific objectives of this study were to secrete proteins into the medium and
assay for their stability and quantity, to express an affinity tag on the protein that
would allow for efficient purification after secretion, and finally to express cleavage
motifs along with an affinity tag in order to remove the target protein from domains
that are nonessential to the function of the protein.
The data presented in the second chapter laid the groundwork for the secretion
of proteins into the medium. It was found that inhibiting the expression of the anchor
region by inserting a stop codon N-terminal to the anchor prevented the anchoring of
the proteins to the surface of S. gordonii. The secretion of the heterologous M6
protein away from the bacteria was clearly shown using immunological assay
methods. During that study it was also found that the overnight growth of
recombinant bacteria without any optimization of medium would yield about 3 mgfL
of target protein.
The data presented in the third chapter showed that the addition of a histidine
tag to either terminus of a heterologous protein secreted from S. gordonii allowed for
purification using immobilized metal affinity chromatography. In this chapter, both
heterologous M6 and nucA were expressed, and purified. NucA showed activity
before and after purification. Again, the study was performed without any growth orexpression optimization. It was found that the expressed proteins could be purified
about 15 fold from the medium.
The data presented in the fourth chapter showed that the expression and
secretion of a fusion protein from S. gordonii containing a mini-intein along with a
chitin binding domain resulted in purification and cleavage of the target protein under
specific conditions. The study shows binding, cleavage, and purification of both M6
and nucA from the medium components. NucA was shown to be active both as a
fusion to the intein/chitin binding domain, and as a pure cleaved protein.
Taken together, this work has shown that this system, termed SPEX for
Surface Protein Expression, can be used not only to secrete proteins into the medium,
but that the expressed proteins can have modifications that allow for better recovery
without interfering with the function of the protein. This system may have broad
application for use in research laboratories and for the production of protein products
for commercial use.
Advantages and Limitationsofthis expression system
This system needs to be optimized in order to express the quantity of protein
that would allow it to compete with other expression systems. The system currently
lacks an inducible promoter for the expression of proteins that may be toxic to the cell,
and an enhanced promoter that would highly increase the expression of proteins. That
limitation aside, SPEX has features that, taken together, most other systems do not.
The expression of engineered proteins from S. gordonii is more cost effective than
yeast and mammalian systems, does not require lysis of the cell as do Gram-negative
expression systems, anchors protein on the cell or secretes it into the medium, and100
does not form insoluble inclusion bodies. S. gordonii is also considered to be a safe
commensal bacterium, which would allow its use as a producer of therapeutics for
human use.
Future directions:
Because of the need for the creation of vaccines and therapeutics, this system
can be used in a variety of ways. It can be used to express antigens on its surface as a
whole cell vaccine system, or to express and secrete heterologous antigens and
therapeutics, which can be purified before use. So far, these therapeutics have not
been developed for humans, but the potential exists.
The protein yield in the SPEX expression system is lower than other systems,
including E. coli and yeast expression systems. In order to be able to compete with
these other systems, the expression level in the SPEX system should be improved.
This system needs the development of better and higher producing promoters, as well
as inducible expression for proteins that might be toxic to the bacterium. Additionally,
the use of multicopy plasmids would also have the advantage of producing greater
amounts of protein for secretion.
Other Gram-positive genera should also be developed for the expression of
heterologous proteins because of the highly conserved anchoring process. Some have
already been developed, and offer distinct advantages based on their potential uses.
For instance, those in the Lactococcus or Lactobacillus species have been used in the
food industry for some time, and they possess an advantage of being approved by the
FDA for use in foods (Langella and Le Loir, 1999; Savijoki et al., 1997). Bacillus
species have also been developed in industry for the expression and secretion of101
heterologous proteins, and much is known about their growth requirements (Kozuka et
al., 2000; Simonen and Palva, 1993).
Lastly, there are other purification and cleavage options that could be
developed in the future, in order to allow the expression system to be used by a greater
number of researchers with different requirements. Additional cloning, expression,
and purification studies will undoubtedly continue to improve the versatility of the
SPEX system.
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